A tissue-engineered scale model of the heart ventricle
Open accessAbstract
Laboratory studies of the heart use cell and tissue cultures to dissect heart function yet rely on animal models to measure pressure and volume dynamics. Here, we report tissue-engineered scale models of the human left ventricle, made of nanofibrous scaffolds that promote native-like anisotropic myocardial tissue genesis and chamber-level contractile function. Incorporating neonatal rat ventricular myocytes or cardiomyocytes derived from human induced pluripotent stem cells, the tissue-engineered ventricles have a diastolic chamber volume of ~500 µl (comparable to that of the native rat ventricle and approximately 1/250 the size of the human ventricle), and ejection fractions and contractile work 50-250 times smaller and 10 4-10 8 times smaller than the corresponding values for rodent and human ventricles, respectively. We also measured tissue coverage and alignment, calcium-transient propagation and pressure-volume loops in the presence or absence of test compounds. Moreover, we describe an instrumented bioreactor with ventricular-assist capabilities, and provide a proof-of-concept disease model of structural arrhythmia. The model ventricles can be evaluated with the same assays used in animal models and in clinical settings.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
26 of 64 cited sources checked · 9 supported · 0 flagged · accuracy not yet measured
- Findingown data
Contractile work of the engineered ventricles is about 10^4-10^8 times smaller than that of rodent and human ventricles.
“ejection fractions and contractile work 50–250 times smaller and 104–108 times smaller than the corresponding values for rodent and human ventricles, respectively.”
- Also stated in: § Discussion · plain
“was less than mouse, rat, or human left ventricles by factors of ~104, 105, and 108, respectively24.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [24] Pacher, P., Nagayama, T., Mukhopadhyay, P., Batkai, S. & Kass, D. A. Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats. Nat. Protoc. 3, 1422–1434 (2008). source
Table 1 (INTRODUCTION; page unavailable) gives stroke-work values for mouse and rat ventricles, providing rodent reference values. It gives no values for engineered or human ventricles and does not establish that engineered ventricles perform 10^4–10^8 times less contractile work. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Also stated in: § Discussion · plain
- Premisecitation
hiPSC-CM are a promising tool for in vitro cardiology with potential to eliminate interspecies and interpersonal variations through patient-specific derivation.
“Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) have emerged as a promising tool for in vitro cardiology, with the potential to eliminate interspecies and interpersonal variations through patient-specific derivation8.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [8] Karakikes, I., Ameen, M., Termglinchan, V. & Wu, J. C. Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes. Circ. Res. 117, 80–88 (2015). source
- Premisecitation
Nanofibers provide biochemical and nanotopographical structural cues with sufficient fidelity to guide cell adhesion, orientation, shape, and assembly.
“Nanofibers provide biochemical and nano-topographical structural cues with sufficient fidelity to guide cell adhesion, orientation, shape, and assembly40,41.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [40] Capulli, A. K., MacQueen, L. A., Sheehy, S. P. & Parker, K. K. Fibrous scaffolds for building hearts and heart parts. Adv. Drug Deliv. Rev. 96, 83–102 (2016). source
- cites [41] Mauck, R. L. et al. Engineering on the straight and narrow: the mechanics of nanofibrous assemblies for fiber-reinforced tissue regeneration. Tissue Eng. Part B 15, 171–193 (2009). source
The knee-meniscus case example reports that aligned nanofibrous scaffolds direct cell polarity and promote ordered collagen deposition; “Enhancing cell infiltration” says biologic nanofibers such as collagen provide an environment for cell adhesion. The broader claim that nanofibers generally provide biochemical cues and guide cell shape is not established by these passages; the adhesion point is specifically about biologic fibers. Page numbers are unavailable in our copy. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Interpretationcitation
These propagation velocities are comparable to those observed in tissues composed of immature cells where cell geometry, calcium handling, gap junction expression and spatial distribution limit conduction velocity compared to mature tissues.
“These values are comparable to those observed in tissues composed of immature cells where cell geometry, calcium handling, gap junction expression and spatial distribution, as well as other factors limit the conduction velocity when compared to mature tissues52,53.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [52] Rohr, S., Kucera, J. P. & Kleber, A. G. Slow conduction in cardiac tissue, I: effects of a reduction of excitability versus a reduction of electrical coupling on microconduction. Circ. Res 83, 781–794 (1998). source
The Abstract reports conduction velocities in cultured neonatal rat ventricular myocytes and identifies gap-junction coupling and geometry as contributors to slowing. The Minimal Pathlengths Supporting Reentrant Excitation section compares neonatal and adult cell length and gap-junction placement, but does not establish that these features, or calcium handling, make immature tissue conduct more slowly than mature tissue. Its discussion of cell length even predicts slightly higher velocities in cultured cells at a given stage of uncoupling. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [53] Yang, X. L., Pabon, L. & Murry, C. E. Engineering adolescence maturation of human pluripotent stem cell-derived cardiomyocytes. Circ. Res. 114, 511–523 (2014). source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
- Premisecitation
Natural contraction rates of cultured cardiomyocytes are ~60-120 bpm (~1-2 Hz).
“Given that natural contraction rates of cultured cardiomyocytes are ~60–120 bpm (~1–2 Hz)16,49”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [16] Mannhardt, I. et al. Human engineered heart tissue: analysis of contractile force. Stem Cell Rep. 7, 29–42 (2016). source
The Results (Functional Characterization of hiPSC-EHTs; page unavailable) report that engineered heart tissues followed electrical pacing at 1–2 Hz, but that is not their natural contraction rate. In the same section, the reported spontaneous rate before drug treatment was 47 ± 6 bpm, below the claimed ~60–120 bpm range. The paper also studies a specific engineered-tissue model, not cultured cardiomyocytes generally. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [49] Meiry, G. et al. Evolution of action potential propagation and repolarization in cultured neonatal rat ventricular myocytes. J. Cardiovasc. Electrophysiol. 12, 1269–1277 (2001). source
- Premisecitation
These features can be recapitulated using nanofibrous materials formed into cellular scaffolds with sufficient porosity to support cell infiltration and promote tissue morphogenesis.
“These features can be recapitulated using nanofibrous materials that are formed into cellular scaffolds with sufficient porosity to support cell infiltration and promote tissue morphogenesis40.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [40] Capulli, A. K., MacQueen, L. A., Sheehy, S. P. & Parker, K. K. Fibrous scaffolds for building hearts and heart parts. Adv. Drug Deliv. Rev. 96, 83–102 (2016). source
- Findingown data
Both NRVM and hiPSC-CM ventricles showed high alignment based on OOP analysis of F-actin stains, with OOP values 0.84 ± 0.02 (NRVM) and 0.85 ± 0.02 (hiPSC-CM).
“Both NRVM and hiPSC-CM ventricles showed high alignment based on OOP analysis of F-actin stains (Supplementary Fig. 3C), with OOP values of 0. 84 ± 0.02 (NRVM) and 0.85 ± 0.02 (hiPSC-CM).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [35] Feinberg, A. W. et al. Controlling the contractile strength of engineered cardiac muscle by hierarchal tissue architecture. Biomaterials 33, 5732–5741 (2012). source
The Results (§3.3; page unavailable) report OOP-based alignment in engineered tissues made from neonatal rat ventricular myocytes. They do not report hiPSC-CM ventricles or the stated OOP values for either cell type; the paper calculated OOP from α-actinin-stained sarcomere Z-disks rather than F-actin stains. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [54] Pasqualini, F. S., Sheehy, S. P., Agarwal, A., Aratyn-Schaus, Y. & Parker, K. K. Structural phenotyping of stem cell-derived cardiomyocytes. Stem Cell Rep. 4, 340–347 (2015). source
The Orientational Order Parameter section (p. 7) defines OOP as a measure of alignment, but the paper’s Figure 2 discussion (p. 5) analyzes sarcomeric α-actinin in cardiomyocyte tissues, not F-actin staining in NRVM and hiPSC-CM ventricles. Searches for those ventricle measurements and the values 0.84 ± 0.02 and 0.85 ± 0.02 found no matching passage in our copy. (LLM, conf=0.74)
Experimental — accuracy not yet measured
- Premisecitation
The model cardiac chamber was developed based on tabulated structural and functional properties of the human left ventricle.
“To begin, we developed a model cardiac chamber based on tabulated structural and functional properties of the human left ventricle40.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [40] Capulli, A. K., MacQueen, L. A., Sheehy, S. P. & Parker, K. K. Fibrous scaffolds for building hearts and heart parts. Adv. Drug Deliv. Rev. 96, 83–102 (2016). source
- Premisecitation
Healthy ventricular musculature arises from coordinated multiscale integration of physical forces transmitted between cells and ECM, and between neighboring cells.
“Healthy ventricular musculature (myocardium) arises from precisely coordinated multiscale integration of physical forces transmitted between cells and the extra-cellular matrix (ECM), as well as between neighboring cells43.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [43] Sheehy, S. P., Grosberg, A. & Parker, K. K. The contribution of cellular mechanotransduction to cardiomyocyte form and function. Biomech. Model. Mechanobiol. 11, 1227–1239 (2012). source
The Introduction describes mechanical forces transmitted between cells and the ECM, and between neighboring cells, as a possible contributor to the form and function of healthy myocardium. It calls multiscale force propagation “one possible mechanism” and says those forces “could prove vital”; the claim presents that proposed role as an established explanation. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Interpretationcitation
The observation of isoproterenol-induced stroke work reduction is consistent with negative force-frequency relationships observed in tissues based on immature cardiomyocytes, including NRVM and hiPSC-CM.
“Our observation of isoproterenol-induced stroke work reduction (Fig. 3b) is consistent with negative force-frequency relationships observed in tissues based on immature cardiomyocytes, including NRVM71 and hiPSC-CM72.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [71] Zimmermann, W. H. et al. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol. Bioeng. 68, 106–114 (2000). source
- cites [72] Germanguz, I. et al. Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells. J. Cell Mol. Med. 15, 38–51 (2011). source
- Findingown data
Proliferative hiPSC (line PGP1-iPSC) seeded in scaffolds at 10^5 cells/cm2 and cultured according to previously described protocols achieved confluence within 4 days of culture.
“For example, proliferative hiPSC (line PGP1-iPSC) seeded in our scaffolds at a density of 105 cells/cm2 and cultured according to previously described protocols11 achieved confluence within 4 days of culture (Supplementary Figure S13A, Day 0).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [11] Wang, G. et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat. Med. 20, 616–623 (2014). source
The Online Methods (labeled Discussion in our copy; page unavailable) describe seeding MACS-purified iPSC-derived cardiomyocytes on muscle thin-film constructs at 10^5 cells/cm², supporting the cited seeding density. They do not describe the PGP1-iPSC line or a protocol for proliferative, undifferentiated hiPSCs. The four-day confluence result is presented as the citing authors’ own observation, not as a finding from this source. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Findingown data
In spontaneously beating tissue-engineered model ventricles, isoproterenol did not produce the positive inotropic effects that others have reported during electrical pacing.
“the positive inotropic effects of isoproterenol observed by others during electrical pacing29 was not observed by us when isoproterenol was administered to spontaneously beating model ventricles (Fig. 3b, right panels).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [29] Li, R. A. et al. Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells. Biomaterials 163, 116–127 (2018). source
- Findingown data
Ejection fractions of the engineered ventricles are about 50-250 times smaller than those of healthy mammalian ventricles.
“ejection fractions and contractile work 50–250 times smaller and 104–108 times smaller than the corresponding values for rodent and human ventricles, respectively.”
- Also stated in: § Discussion · plain
“equivalent to ejection fractions, EF ~ 0.2–1%, which are smaller than expected for healthy mammalian ventricles by factors of roughly 50–250.”
Quote in the paperSubstantial claim - Also stated in: § Discussion · plain
- Findingown data
The two-hole injury generated counter-propagating spiral waves that merged within the region between holes.
“The two-hole injury generated counter-propagating spiral waves that merged within the region between holes (Fig. 5a, third row).”
Quote in the paperNot a substantial claim - Findingown data
Gelatin incorporated into nanofibers persisted for at least 4 days in aqueous solutions according to XPS measurements.
“Gelatin incorporated into the nanofibers persisted for at least 4 days in aqueous solutions according to measurements made using X-ray photoelectron spectroscopy (Supplementary Fig. S2B).”
Quote in the paperNot a substantial claim - Findingown data
Assisted pumping was demonstrated in the absence of drugs by controlling pressure delivered to the external assist channel using a pressure-driven programmable pump and cast-molded silicone tricuspid valves to direct flow.
“We demonstrated assisted pumping in the absence of drugs by controlling pressure delivered to the external (assist) channel using a pressure-driven programmable pump and cast-molded silicone tricuspid valves to direct flow (Fig. 4a, Supplementary Fig. S9).”
Quote in the paperSubstantial claim - Findingown data
Synchronous chamber-level contraction was observed for both NRVM and hiPSC-CM after 3-5 days of culture in scaffolds.
“Synchronous chamber-level contraction was observed for both cell types after 3–5 days of culture in the scaffolds.”
Quote in the paperSubstantial claim - Findingown data
SEM confirmed PCL/gelatin nanofiber scaffolds were structurally comparable with decellularized human left ventricle tissue.
“Here, we used scanning electron microscopy (SEM) to confirm that PCL/gelatin nanofiber scaffolds were structurally comparable with decellularized human left ventricle tissue (Supplementary Fig. S2A).”
Quote in the paperSubstantial claim - Findingreasoning
Using parameter values from scaffolds (R=5 mm, h=0.1 mm, 50 kPa < E < 500 kPa) gives bending resonant frequencies 0.67 Hz < fB < 2 Hz, matching cardiomyocyte contraction rates.
“Using parameter values from our scaffolds (R = 5 mm, h = 0.1 mm, 50 kPa < E < 500 kPa) gives bending resonant frequencies of 0.67 Hz < fB < 2 Hz, where fB = ωB/2π, which match the contraction rates of cardiomyocytes.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] Morse, P. M. & Feshbach, H. Methods of Theoretical Physics (McGraw-Hill, New York, 1953).
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingown data
Calcium imaging revealed continuous excitation propagation on ventricle surfaces, confirming electrical continuity throughout ventricle constructs.
“Calcium imaging, which has been used as a surrogate for the action potential51, revealed continuous excitation propagation on the ventricle surfaces, confirming electrical continuity throughout the ventricle constructs (Fig. 1d, Supplementary Movies 6,7).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [51] Mandegar, M. A. et al. CRISPR interference efficiently induces specific and reversible gene silencing in human iPSCs. Cell Stem Cell 18, 541–553 (2016). source
- Findingown data
Immunostaining confirmed fiber-directed anisotropic cell alignment and infiltration within chamber wall.
“Immunostaining confirmed fiber-directed anisotropic cell alignment and infiltration within the chamber wall (Fig. 2, Supplementary Fig. S3, S4, Supplementary Movie 8)”
Quote in the paperSubstantial claim - Findingown data
Beat rate decreased as bath temperature was decreased from physiological 37°C to less than ~30°C, as judged by shift in frequency spectrum.
“Furthermore, we observed an expected reduction in beat rate, as judged by a shift in the frequency spectrum, as bath temperature was decreased from physiological 37°C to less than ~30°C (Supplementary Fig. S7C).”
Quote in the paperNot a substantial claim - Findingown data
The tensile elastic modulus of scaffolds was anisotropic, with longitudinal EL = 500 ± 31 kPa and transverse ET = 74 ± 15 kPa.
“The tensile elastic modulus of our scaffolds was anisotropic, with values measured longitudinally (in the direction parallel to the fiber axis), EL = 500 ± 31 kPa, or transverse (in the direction perpendicular to the fiber axis), ET = 74 ± 15 kPa (Supplementary Fig. S2C).”
Quote in the paperSubstantial claim - Findingown data
Ventricle contraction was monitored by ultrasound through removable elastomeric windows in the HBR.
“we monitored ventricle contraction by ultrasound through removable elastomeric windows in the HBR (Fig. 4c, Supplementary Fig. S10, Supplementary Movies 10,11).”
Quote in the paperSubstantial claim - Findingown data
Preliminary work in our laboratories suggests that extended culture periods for NRVM and hiPSC-CM in nanofibrous scaffolds can be achieved.
“Preliminary work in our laboratories suggest that we can achieve extended culture periods for NRVM (Supplementary Fig. S12, Supplementary Movies S14, 15) and hiPSC-CM (Supplementary Figs. S13, S14) in our nanofibrous scaffolds.”
Quote in the paperNot a substantial claim - Findingown data
Calcium mapping of pre-injured ventricles on day 11 was prevented from stable rotor pinning because tissue had grown into the injury site.
“Calcium mapping of pre-injured ventricles was done on day 11 but tissue had grown into the injury site, preventing stable rotor pinning.”
Quote in the paperNot a substantial claim - Findingown data
Volume estimates from the conductance slope and from scaffold filling agreed well within a working volume range of about 300-600 μL.
“Volume estimated by calculating the slope of measured conductance versus cuvette volume (Supplementary Fig. 4B.i) or by scaffold filling (Supplementary Fig. 4B.ii) were in good agreement within a relevant working volume range of ~300–600 μL.”
Quote in the paperSubstantial claim - Findingown data
Precise anatomical defects applied to the tissue-engineered model ventricles generated stable pinned rotors and spiral waves.
“Precise anatomical defects applied to our tissue engineered model ventricles generated stable pinned rotors and spiral waves (Fig. 5, Supplementary Fig. 11, Supplementary Movies S12, S13)”
Quote in the paperSubstantial claim - Findingown data
Contractile strength of the model ventricles increased during preliminary extended culture period experiments.
“contractile strength increased in our preliminary extended culture period experiments (Supplementary Fig. S14).”
Quote in the paperNot a substantial claim - Interpretationnone given
The model ventricles can be evaluated with the same assays used in animal models and clinical settings.
“The model ventricles can be evaluated with the same assays used in animal models and in clinical settings.”
Quote in the paperNot a substantial claim - Interpretationown data
Model ventricles are suitable for cardiac arrhythmia studies.
“and suggest that model ventricles are suitable for cardiac arrhythmia studies.”
- Also stated in: § Structural arrhythmia disease model · hedged
“These results suggest the feasibility of using tissue engineered heart chambers to study arrhythmogenic heart diseases.”
Quote in the paperSubstantial claim - Also stated in: § Structural arrhythmia disease model · hedged
- Premisereasoning
Lack of in vitro models based on hiPSC-CM that accurately reproduce heart chamber architecture and functional output is a significant limitation because tissue performance cannot be directly compared to animal or human heart performance measured by chamber pressure and volume.
“However, the lack of in vitro models based on hiPSC-CM that accurately reproduce the architecture and functional output of the heart chambers9,10,23 is a significant limitation because tissue performance cannot be directly compared to animal or human heart performance, which are evaluated by measuring changes in chamber pressure and volume24,25.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [9] Feric, N. T. & Radisic, M. Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues. Adv. Drug Deliv. Rev. 96, 110–134 (2016). source
- cites [10] Eder, A., Vollert, I., Hansen, A. & Eschenhagen, T. Human engineered heart tissue as a model system for drug testing. Adv. Drug Deliv. Rev. 96, 214–224 (2016). source
- cites [23] Mathur, A., Ma, Z., Loskill, P., Jeeawoody, S. & Healy, K. E. In vitro cardiac tissue models: current status and future prospects. Adv. Drug Deliv. Rev. 96, 203–213 (2016). source
- Interpretationown data
Findings confirm that tissue-engineered model ventricle contraction can be monitored by catheter sensors.
“Our findings confirm that tissue-engineered model ventricle contraction can be monitored by catheter sensors”
Quote in the paperSubstantial claim - Interpretationown data
This suggests a natural design principle to engineer artificial ventricles as a function of natural frequencies of cardiomyocyte contraction.
“This suggests a natural design principal to engineer artificial ventricles as a function of the natural frequencies of cardiomyocyte contraction.”
- Also stated in: § Discussion · hedged
“Our calculations of resonant bending frequencies suggests a natural design principal to engineer cardiac chambers as a function of their intended beat rates.”
Quote in the paperSubstantial claim - Also stated in: § Discussion · hedged
- Premisenone given
PCL provides structural stability for scaffold nanofibrous features during culture.
“PCL provides structural stability for the scaffold’s nanofibrous features during culture”
Quote in the paperSubstantial claim - Premisecitation
In myocardial tissues, anatomical structures can introduce heterogeneities of impulse conduction that lead to ventricular tachycardia, including spiral waves anchored to anatomical defects.
“In myocardial tissues, anatomical structures can introduce heterogeneities of impulse conduction that lead to ventricular tachycardia, including spiral waves anchored to anatomical defects33,62.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [33] Kleber, A. G. & Rudy, Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol. Rev. 84, 431–488 (2004). source
- cites [62] Lim, Z. Y., Maskara, B., Aguel, F., Emokpae, R.Jr & Tung, L. Spiral wave attachment to millimeter-sized obstacles. Circulation 114, 2113–2121 (2006). source
- Study design and conductnone given
Overnight exposure to ultraviolet radiation was sufficient to prevent bacterial contamination of the scaffolds.
“Overnight exposure to UV was sufficient to prevent bacterial contamination”
Quote in the paperNot a substantial claim - Interpretationreasoning
The ability to tissue-engineer functional model ventricles and the modular bioreactor technologies for in situ instrumentation and functional assessment together provide a suitable system for in vitro cardiology studies that increasingly translate to clinical outcomes.
“the capability to tissue-engineer functional model ventricles, and the modular bioreactor technologies designed for in situ instrumentation and functional assessment, provide a suitable system for in vitro cardiology studies that increasingly translate to clinical outcomes.”
Quote in the paperNot a substantial claim - Interpretationown data
The results demonstrate that functional scale models of heart chambers can be engineered when tissue assembly is guided by a nanofibrous culture substrate.
“our results demonstrate the feasibility of engineering functional scale models of the heart chambers, where tissue assembly is guided by a nanofibrous culture substrate”
Quote in the paperSubstantial claim - Interpretationreasoning
The structural arrhythmia disease model reaffirmed the importance of building native-like anisotropic tissues.
“our structural arrhythmia disease model reaffirmed the importance of building native-like anisotropic tissues”
Quote in the paperSubstantial claim - Premisecitation
Native-like anisotropic tissues are important for both normal propagation and arrhythmogenesis.
“the importance of building native-like anisotropic tissues that are important for both normal propagation and arrhythmogenesis33.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] Kleber, A. G. & Rudy, Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol. Rev. 84, 431–488 (2004). source
- Interpretationreasoning
The design rules provide a path toward engineering heart chambers whose functional performance is increasingly comparable to native organs.
“our design rules provide a path toward engineering heart chambers with functional performance increasingly comparable to native organs.”
Quote in the paperNot a substantial claim - Study design and conductown data
Pressure and volume variations generated by the tissue-engineered model ventricles were verified to be above the noise floor.
“we verified that pressure and volume variations generated by our tissue engineered model ventricles were above the noise floor (Supplementary Figs. S5–S7).”
Quote in the paperSubstantial claim - Interpretationown data
Direct comparison of engineered ventricle chamber contractile performance with ex-vivo animal studies is challenging.
“A direct comparison of engineered ventricle chamber contractile performance with those of ex-vivo animal studies is challenging.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 11
- May combine two claims. 43
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAnimal models and isolated heart preparations are evaluated using pre-clinical and clinical modalities such as catheterization, echocardiography, and MRI.
“animal models and isolated heart preparations are evaluated using pre-clinical and clinical measurement modalities such as catheterization3, echocardiography4, and magnetic resonance imaging5.”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [3] Pacher, P., Nagayama, T., Mukhopadhyay, P., Batkai, S. & Kass, D. A. Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats. Nat. Protoc. 3, 1422–1434 (2008). source
The Introduction describes catheterization to measure cardiac function in mouse and rat animal models, including intact beating hearts. It does not establish the cited technique's use in isolated heart preparations. Citation 3 is attached to catheterization, so the separate echocardiography and MRI citations are not assessed here. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [4] Ram, R., Mickelsen, D. M., Theodoropoulos, C. & Blaxall, B. C. New approaches in small animal echocardiography: imaging the sounds of silence. Am. J. Physiol. Heart Circ. Physiol. 301, H1765–1780 (2011). source
- cites [5] Bakermans, A. J. et al. Small animal cardiovascular MR imaging and spectroscopy. Prog. Nucl. Magn. Reson. Spectrosc. 88–89, 1–47 (2015). source
May combine two claims.
PremisecitationData from animal models allow direct comparison to patient data, but differences in genetics, physiology, and disease etiology limit their utility for developing therapeutic interventions.
“Data obtained using these methods allow direct comparison to patient data, but differences in genetics, physiology and disease etiology limit the utility of animal models for developing therapeutic interventions6,7.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [6] Chandrasekera, P. C. & Pippin, J. J. The human subject: an integrative animal model for 21st century heart failure research. Am. J. Transl. Res. 7, 1636–1647 (2015).
- cites [7] Gloschat, C. R. et al. Arrhythmogenic and metabolic remodelling of failing human heart. J. Physiol. 594, 3963–3980 (2016). source
The Introduction says animal models may not reproduce the varied causes of human heart failure and that these differences limit translation to clinical therapies. The Conclusions also identify species and physiological differences as barriers. Our copy does not establish that data obtained using the citing paper’s methods allow direct comparison with patient data, or specifically identify genetic differences between animal models and humans as a barrier. (LLM, conf=0.83)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationMyocardial ECM is fibrillar, anisotropic, and provides nanotopographical cues that guide cardiomyocyte alignment and assembly, ultimately forming a helicoid structure that optimizes ejection fraction during ventricular contraction.
“The myocardial ECM is fibrillar, anisotropic, and provides nanotopographical cues that guide cardiomyocyte alignment and assembly44, ultimately forming a helicoid structure that optimizes ejection fraction during ventricular contraction45.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [44] Kim, D. H. et al. Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs. Proc. Natl Acad. Sci. USA 107, 565–570 (2010). source
- cites [45] Savadjiev, P. et al. Heart wall myofibers are arranged in minimal surfaces to optimize organ function. Proc. Natl Acad. Sci. USA 109, 9248–9253 (2012). source
May combine two claims.
PremisecitationEngineered cardiac organoid chambers made of cardiomyocytes in isotropic hydrogels showed promise for intra-ventricular pressure measurements, but lack of scaffold hampers formation of organized tissues recapitulating native myocardial laminar architecture.
“Engineered cardiac organoid chambers comprised of cardiomyocytes embedded in isotropic hydrogels showed significant promise for obtaining intra-ventricular pressure measurements26–29 but the lack of a scaffold to guide cell assembly hampers the formation of organized tissues that recapitulate the laminar architecture30,31 of the native myocardium.”
Quote in the paperSubstantial claim1 of 6 sources checked- cites [26] Lee, E. J., Kim do, E., Azeloglu, E. U. & Costa, K. D. Engineered cardiac organoid chambers: toward a functional biological model ventricle. Tissue Eng. Part A 14, 215–225 (2008). source
- cites [27] Gonen-Wadmany, M., Gepstein, L. & Seliktar, D. Controlling the cellular organization of tissue-engineered cardiac constructs. Ann. N. Y. Acad. Sci. 1015, 299–311 (2004). source
- cites [28] Yildirim, Y. et al. Development of a biological ventricular assist device: preliminary data from a small animal model. Circulation 116, I-16–I-23 (2007). source
- cites [29] Li, R. A. et al. Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells. Biomaterials 163, 116–127 (2018). source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [30] Costa, K. D., Takayama, Y., McCulloch, A. D. & Covell, J. W. Laminar fiber architecture and three-dimensional systolic mechanics in canine ventricular myocardium. Am. J. Physiol. 276, H595–607 (1999). source
- cites [31] Arts, T., Costa, K. D., Covell, J. W. & McCulloch, A. D. Relating myocardial laminar architecture to shear strain and muscle fiber orientation. Am. J. Physiol. Heart Circ. Physiol. 280, H2222–2229 (2001). source
May combine two claims.
PremisecitationPCL/gelatin nanofibers are biocompatible, biodegradable, promote cell adhesion, provide sufficient structural integrity for ventricle culture and catheterization, and can be produced by various nanofiber production systems including electrospinning and force-spinning.
“We selected polycaprolactone (PCL)/gelatin nanofibers as our material of choice because they are biocompatible and biodegradable, they promote cell adhesion, provide sufficient structural integrity for ventricle culture and catheterization, and can be produced by a variety of nanofiber production systems that include electrospinning and force-spinning methods40.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [40] Capulli, A. K., MacQueen, L. A., Sheehy, S. P. & Parker, K. K. Fibrous scaffolds for building hearts and heart parts. Adv. Drug Deliv. Rev. 96, 83–102 (2016). source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Classified as probably not a substantial claim.
PremisecitationIn native heart, overlapping myocardial fibers are arranged into distinct laminae four to six myocytes thick and separated from adjacent laminae by an extracellular collagen network.
“In the native heart, overlapping myocardial fibers are arranged into distinct laminae four to six myocytes thick and separated from adjacent laminae by an extracellular collagen network42.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [42] Pope, A. J., Sands, G. B., Smaill, B. H. & LeGrice, I. J. Three-dimensional transmural organization of perimysial collagen in the heart. Am. J. Physiol. Heart C 295, 1243–1252 (2008). source
The Discussion (3-D perimysial collagen organization; page unavailable) describes branching myocardial layers grouped by perimysial collagen and reports them as approximately four cells thick, not four to six. The Results (page unavailable) show collagen between adjacent layers, but the paper also says laminar structure is not evident in the outer 10–20% of the rat left ventricle, so the claim is too general. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
FindingcitationCardiomyocyte spontaneous beat rates in our model ventricles were similar to other in vitro assays based on NRVM or hiPSC-CM, showing moderate positive chronotropy (~40% beat rate).
“Cardiomyocyte spontaneous beat rates in our model ventricles were similar to other in vitro assays based on NRVM49 or hiPSC-CM16, showing moderate positive chronotropy (~40% beat rate)10,18.”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [49] Meiry, G. et al. Evolution of action potential propagation and repolarization in cultured neonatal rat ventricular myocytes. J. Cardiovasc. Electrophysiol. 12, 1269–1277 (2001). source
- cites [16] Mannhardt, I. et al. Human engineered heart tissue: analysis of contractile force. Stem Cell Rep. 7, 29–42 (2016). source
- cites [10] Eder, A., Vollert, I., Hansen, A. & Eschenhagen, T. Human engineered heart tissue as a model system for drug testing. Adv. Drug Deliv. Rev. 96, 214–224 (2016). source
May combine two claims.
InterpretationcitationModerate positive chronotropy and reduction of stroke work at high isoproterenol doses are characteristic of immature tissues exhibiting poorly developed calcium handling, suggesting maturation protocols may be required to obtain positive force-frequency relationships as observed in healthy adult human ventricular myocardium.
“The moderate positive chronotropy and reduction of stroke work observed at high isoproterenol doses are characteristic of immature tissues exhibiting poorly developed calcium handling properties8, suggesting that maturation protocols14,21,22,73 may be required to obtain positive force-frequency relationships, as observed in healthy adult human ventricular myocardium74.”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [8] Karakikes, I., Ameen, M., Termglinchan, V. & Wu, J. C. Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes. Circ. Res. 117, 80–88 (2015). source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [14] Nunes, S. S. et al. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat. Methods 10, 781–787 (2013). source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [74] Endoh, M. Force–frequency relationship in intact mammalian ventricular myocardium: physiological and pathophysiological relevance. Eur. J. Pharmacol. 500, 73–86 (2004). source
May combine two claims.
FindingcitationContractile work in our ventricle models was measured using conductance catheters and was smaller than reported for cardiac organoid chambers based on NRVM or pluripotent hES2 human embryonic stem cell-derived cardiomyocytes, where volume changes were indirectly assessed from video recordings.
“Contractile work in our ventricle models was measured using conductance catheters and was smaller than reported for cardiac organoid chambers based on NRVM26 or pluripotent hES2 human embryonic stem cell-derived cardiomyocytes29, where volume changes were indirectly assessed from video recordings.”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [26] Lee, E. J., Kim do, E., Azeloglu, E. U. & Costa, K. D. Engineered cardiac organoid chambers: toward a functional biological model ventricle. Tissue Eng. Part A 14, 215–225 (2008). source
- cites [29] Li, R. A. et al. Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells. Biomaterials 163, 116–127 (2018). source
May combine two claims.
FindingcitationThe tensile elastic modulus of our scaffold in the direction of fiber alignment (EL ~500 kPa) was higher than healthy ventricular ECM (E ~350 kPa) and may have limited cardiomyocyte shortening during contraction.
“For example, the tensile elastic modulus of our scaffold in the direction of fiber alignment (EL ~ 500 kPa) was higher than healthy ventricular ECM (E ~350 kPa)68 and may have limited cardiomyocyte shortening during contraction.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [68] Quinn, K. P. et al. Optical metrics of the extracellular matrix predict compositional and mechanical changes after myocardial infarction. Sci. Rep. 6, 35823 (2016). source
The Results report tensile testing of healthy ventricular ECM and its elastic modulus, supporting the use of this paper as a comparator. But the available text does not give the cited value of approximately 350 kPa (searched: “350” and “kPa”). The scaffold modulus and possible effect on cardiomyocyte shortening are the citing authors’ own comparison and inference, not findings attributed to this source. (LLM, conf=0.83)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataThe engineered ventricles seeded with NRVM or hiPSC-CM have a diastolic chamber volume of about 500 μL, similar to native rat ventricle and about 1/250 of human ventricle.
“Incorporating neonatal rat ventricular myocytes or cardiomyocytes derived from human induced pluripotent stem cells, the tissue-engineered ventricles have a diastolic chamber volume of ~500 μL (comparable to that of the native rat ventricle and approximately 1/250 the size of the human ventricle)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataEngineered scale-model ventricles of the human left heart, built from nanofibrous scaffolds, support anisotropic myocardial tissue formation and chamber-level contraction.
“Here, we report tissue-engineered scale models of the human left ventricle, made of nanofibrous scaffolds that promote native-like anisotropic myocardial tissue genesis and chamber-level contractile function.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn all cases, spontaneous calcium activity showed stable excitation patterns with plane waves (healthy) or pinned spiral waves (injured) repeating at a near-constant rate between 4 Hz and 5 Hz for the duration of experiments (~2 hours).
“In all cases, spontaneous calcium activity showed stable excitation patterns with plane waves (healthy) or pinned spiral waves (injured) repeating at a near-constant rate (between 4 Hz and 5Hz) for the duration of experiments (~2 hours).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPressure/volume loops measured before and after isoproterenol exposure showed an isoproterenol-induced reduction in stroke work, concomitant with an increase in beat frequency.
“Pressure/volume loops measured before and after isoproterenol exposure showed an isoproterenol-induced reduction in stroke work, concomitant with an increase in beat frequency (Fig. 3b,c).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPlane wave propagation was observed prior to injury, whereas injured ventricles generated spiral waves that were pinned to controlled anatomical defects.
“Plane wave propagation was observed prior to injury (Fig. 5a, top), whereas injured ventricles generated spiral waves that were pinned to the controlled anatomical defects (Fig. 5a, bottom panels, and Supplementary Movie 12).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe self-contained instrumented heart bioreactor includes intra- and extra-ventricular flow loops, separate chambers for optional valve inserts, and additional access ports for catheters.
“The HBR includes both intra- and extra- ventricular flow loops, separate chambers for optional valve inserts, and additional access ports for catheters (Fig. 4a, Supplementary Fig. S8).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMean calcium wavefront propagation velocity from apex to base was 9.33 cm/sec for NRVM and 5.2 cm/sec for hiPSC-CM ventricles.
“Mean calcium wavefront propagation velocity from apex to base was 9.33 cm/sec or 5.2 cm/sec for NRVM or hiPSC-CM ventricles, respectively.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe engineered ventricle chambers were sutured to tubing or bioreactor components, and stable contraction of NRVM and hiPSC-CM ventricles permitted time-dependent pressure and volume measurements.
“The resulting tissue-engineered ventricle chambers were sutured to tubing or bioreactor components through which catheter sensors were introduced and stable contraction of both NRVM and hiPSC-CM ventricles permitted time-dependent pressure and volume measurements.”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenIn our scaffold, gelatin enhanced cell and biomolecule adhesion during cell seeding, and PCL provided structural features (microporosity, nanotopography, anisotropy) that resisted degradation during culture.
“In our scaffold, gelatin was used to enhance cell and biomolecule adhesion during cell seeding, and the polymer backbone (PCL) provided structural features (microporosity, nanotopography, anisotropy) that resisted degradation during culture.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCalcium fluorescence intensity measured near the rotor poles of a single-hole injury model showed consistent phase difference and a rotation rate of ~5 Hz.
“Calcium fluorescence intensity measured near the rotor poles of a single-hole injury model showed consistent phase difference and a rotation rate of ~ 5 Hz (Fig. 5b, Supplementary Figure S12, and Supplementary Movie 13).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataUsing small animal echocardiography equipment, both unassisted natural spontaneous ventricle contraction and HBR-assisted contraction were recorded.
“Using small animal echocardiography equipment, we recorded both unassisted natural spontaneous ventricle contraction (Fig. 4c, left, and Supplementary Movie 10) and HBR-assisted contraction (Fig. 4c, right, and Supplementary Movie 11).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMeasured differences in chamber pressure were ~50 μmHg for rat or human ventricles, and volume change was ~5 μL (rat) or 1 μL (human).
“Measured differences in chamber pressure were ~50 μmHg (rat or human) and the volume change was ~5 μL (rat) or 1 μL (human).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSynchronous, coordinated ventricle contraction developed spontaneously after 3-5 days of culture and persisted for duration of experimental procedures conducted 14 days after seeding.
“Synchronous, coordinated ventricle contraction developed spontaneously after 3–5 days of culture (Supplementary Movies 3,4) and persisted for the duration of experimental procedures (Supplementary Movie 5), conducted 14 days after seeding.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCyclic pressure applied to the extra-ventricular loop drives intra-ventricular fluid flow via assisted ventricle contraction, and unidirectional flow can be achieved using commercially available valves or custom valve inserts.
“Cyclic pressure applied to the extra-ventricular loop drives intra-ventricular fluid flow via assisted ventricle contraction, and unidirectional flow can be achieved using commercially available valves or with custom valve inserts in the HBR.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationVentricle beat rates showed a positive chronotropic response over the concentration range in both NRVM and hiPSC-CM ventricles, as expected for healthy NRVM, hiPSC-CM, engineered hiPSC-CM cardiac tissues, and human patients.
“Ventricle beat rates showed a positive chronotropic response over the concentration range in both the NRVM and hiPSC-CM ventricles (Fig. 3c), as expected for healthy NRVM59, hiPSC-CM60, engineered hiPSC-CM cardiac tissues16, and human patients61.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [59] Simpson, P. & Savion, S. Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol. Circ. Res. 50, 101–116 (1982). source
- cites [60] Moretti, A. et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397–1409 (2010). source
- cites [61] Koglin, J., Bohm, M., Vonscheidt, W., Stablein, A. & Erdmann, E. Antiadrenergic effect of carbachol but not of adenosine on contractility in the intact human ventricle in-vivo. J. Am. Coll. Cardiol. 23, 678–683 (1994). source
May combine two claims.
Findingown dataSpontaneous beat rate of NRVM ventricles (~130 ±15 bpm) was higher than hiPSC-CM ventricles (~85 ± 15 bpm), and both increased by ~40% following exposure to 10−4 M isoproterenol.
“The spontaneous beat rate of NRVM ventricles (~130 ±15 bpm) was higher than hiPSC-CM ventricles (~85 ± 15 bpm), and both increased by ~40% following exposure to 10−4 M isoproterenol.”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningThese scaffold features provided sufficient structural integrity for ventricle culture and guided cardiomyocyte assembly.
“These features provided sufficient structural integrity for ventricle culture and they guided cardiomyocyte assembly”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningEjection fractions were ~1% (rat) or ~0.2% (human) and stroke work was ~0.25 mmHg × μL (rat) or ~0.05 mmHg × μL (human).
“Thus, ejection fractions were ~1% (rat) or ~0.2% (human) and stroke work was WS ~ 0.25 mmHg × μL (rat) or WS ~ 0.05 mmHg × μL (human).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataRegular beat frequencies were observed in calcium-containing M199 or Tyrode's solution, whereas exposure to calcium-free PBS led to broad beat rate distributions.
“Whereas regular beat frequencies were observed in calcium-containing M199 or Tyrode’s solution, exposure to calcium-free PBS led to broad beat rate distributions (Supplementary Fig. S7B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataA non-proliferative hiPSC-CM line (Cor.4U) cultured in model ventricle scaffolds for 6 months preserved tissue anisotropy and stable pressure-volume loops could be recorded.
“We also cultured a non-proliferative hiPSC-CM line (Cor.4U) in model ventricle scaffolds for 6 months, demonstrating that tissue anisotropy was preserved (Supplementary Figure S14A) and stable pressure-volume loops could be recorded (Supplementary Figure S14 B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataWhen cultured in differentiation media, resulting hiPSC-CM showed spontaneous contraction and early stages of sarcomeric assembly within 8-12 days, and anisotropic sarcomeric assembly with early z-disk alignment after 1 month.
“When cultured in differentiation media, the resulting hiPSC-CM showed spontaneous contraction and early stages of sarcomeric assembly within 8–12 days of culture (Supplementary Figure S13A, Day 12), and anisotropic sarcomeric assembly with early stages of z-disk alignment after 1 month in culture (Supplementary Figure S13A, Day 30).”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationBoth types of model cardiac chambers generated similarly shaped elliptical PV-loops, which are expected from ventricles contracting in the absence of valves and show similarities to PV loops obtained from patients with severe valvular insufficiencies.
“Both types of model cardiac chambers generated similarly shaped elliptical PV-loops (Fig. 3b, Supplementary Fig. S14), which are expected from ventricles contracting in the absence of valves and show similarities to PV loops obtained from patients with severe valvular insufficiencies78.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [78] Klabunde, R. E. Cardiovascular Physiology Concepts 2nd edn (Lippincott Williams & Wilkins/Wolters Kluwer, Philadelphia, 2012).
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingreasoningThe EF of our tissue-engineered rat ventricles was ~1% (1/50 EF of healthy rats), suggesting that discontinuities in cardiomyocyte coverage limited tissue-engineered ventricle contractile strength.
“The EF of our tissue-engineered rat ventricles was ~1% (1/50 EF of healthy rats), suggesting that discontinuities in cardiomyocyte coverage limited tissue-engineered ventricle contractile strength.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationThe conductance/volume catheter response was non-linear, as expected for these systems.
“We observed a non-linear conductance/volume catheter response (Supplementary Fig. 4B.i), as expected for these systems82.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [82] Pearce, J. A., Porterfield, J. E., Larson, E. R., Valvano, J. W. & Feldman, M. D. Accuracy considerations in catheter based estimation of left ventricular volume. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2010, 3556–3558 (2010). source
May combine two claims.
Findingown dataBoth uninjured ventricles showed evidence of spontaneously generated calcium plane wave propagation, but one had greater homogeneity.
“Both showed evidence of spontaneously generated calcium plane wave propagation but one had greater homogeneity; this favorable sample is reported in our revised manuscript.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataCell density in our ventricles, estimated by counting immunostained NRVM ventricle surfaces and cross-sections, was ~90,000 cells/mm3 for a total cell number ~2.3 × 10^6 in a 26 mm3 scaffold volume, approximately 10-fold less than in 21-day-old or 3-month-old rat hearts.
“The cell density in our ventricles, estimated by counting immunostained (DAPI) NRVM ventricle surfaces and cross-sections (Supplementary Fig. S3), was ~90,000 cells/mm3 for a total cell number ~2.3 × 106 in a 26 mm3 scaffold volume, which is approximately 10-fold less than in 21-day-old or 3-month-old rat hearts75.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [75] Bai, S. L., Campbell, S. E., Moore, J. A., Morales, M. C. & Gerdes, A. M. Influence of age, growth, and sex on cardiac myocyte size and number in rats. Anat. Rec. 226, 207–212 (1990). source
Probably not a substantial claim: may not pass S4 (based).
Premisenone givenDirect comparison with natural ventricle pressure and volume dynamics requires three-dimensional contractile cardiac chambers.
“but direct comparison with natural ventricle pressure and volume dynamics requires three-dimensional (3D) contractile cardiac chambers.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationhiPSC-CM are assembled into functional engineered heart tissues, including muscular thin films or 3D muscle strips, to model contractile pathophysiologies, promote maturation, and produce drug responses increasingly comparable to human patients.
“These cells are assembled into functional engineered heart tissues2,9,10, including muscular thin films11,12 or 3D muscle strips13–20, to model contractile pathophysiologies11, promote hiPSC-CM maturation9,14,15,21, and produce drug responses that are increasingly comparable to human patients16,18,22.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [2] Tzatzalos, E., Abilez, O. J., Shukla, P. & Wu, J. C. Engineered heart tissues and induced pluripotent stem cells: macro- and microstructures for disease modeling, drug screening, and translational studies. Adv. Drug Deliv. Rev. 96, 234–244 (2016). source
- cites [9] Feric, N. T. & Radisic, M. Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues. Adv. Drug Deliv. Rev. 96, 110–134 (2016). source
- cites [10] Eder, A., Vollert, I., Hansen, A. & Eschenhagen, T. Human engineered heart tissue as a model system for drug testing. Adv. Drug Deliv. Rev. 96, 214–224 (2016). source
Classified as probably not a substantial claim. May combine two claims.
PremisereasoningHigh maintenance costs and low experimental throughput of animal models motivate development of alternative in vitro cardiology assays based on human cells.
“These and other limitations associated with animal models, for example high maintenance costs and low experimental throughput, motivate the development of alternative in vitro cardiology assays based on human cells.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThese scaffold properties allowed fabrication of ventricle scaffolds that were structurally stable and permissive to chamber contraction by cardiomyocyte shortening.
“These properties allowed us to fabricate ventricle scaffolds that were both structurally stable and permissive to chamber contraction by cardiomyocyte shortening.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningEchocardiography performed in the absence of extra-ventricular tissues can improve image clarity compared with in vivo studies, underscoring the advantage of organ modularity in the HBR.
“Echocardiography performed in the absence of extra-ventricular tissues can improve image clarity compared with in vivo studies, underscoring the advantage of organ modularity in our HBR.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIn this configuration, cultured ventricles can be exposed to externally-controlled physiological or pathological pressure variations and PV loops acquired with or without valves.
“In this configuration, cultured ventricles can be exposed to externally-controlled physiological or pathological pressure variations and PV loops acquired with or without valves (Fig. 4b)”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAnisotropic PCL/gelatin nanofiber production by pull spinning and their use to guide skeletal muscle tissue assembly were previously described.
“We previously described anisotropic PCL/gelatin nanofiber production by pull spinning and their use to guide skeletal muscle tissue assembly46.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Deravi, L. F. et al. Design and fabrication of fibrous nanomaterials using pull spinning. Macromol. Mater. Eng. 302, 1600404 (2017). source
May combine two claims.
PremisecitationThe myocardium is a composite in which the dominant stiffness shifts from myocytes to the ECM with increasing strain, emphasizing the ECM's role maintaining structural integrity.
“Scaffold engineering should account for the fact that the myocardium is a composite in which the dominant stiffness shifts from myocytes to the ECM with increasing strain67, emphasizing the ECM’s role maintaining structural integrity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Chaturvedi, R. R. et al. Passive stiffness of myocardium from congenital heart disease and implications for diastole. Circulation 121, 979–988 (2010). source
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningResults have implications for preclinical cardiology and regenerative medicine research where human organ models are sought to improve translation of therapeutic strategies.
“These results have implications for preclinical cardiology and regenerative medicine research where human organ models are sought to improve translation of therapeutic strategies.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationResponse to adrenergic agonists is a fundamental aspect of myocardial function, studied extensively in rodents and humans, making β-adrenergic response a good test of engineered ventricles' ability to recapitulate normal cardiac pharmacology.
“A fundamental aspect of myocardial function is the response to adrenergic agonists, which has been studied extensively in both rodents and humans, making β-adrenergic response a good test of the ability of our engineered ventricles to recapitulate normal cardiac pharmacology57,58.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [57] Barrett, A. M. & Carter, J. Comparative chronotropic activity of beta-adrenoceptive antagonists. Br. J. Pharmacol. 40, 373–381 (1970). source
- cites [58] Brito-Martins, M., Harding, S. E. & Ali, N. N. Beta(1)- and beta(2)-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart. Br. J. Pharmacol. 153, 751–759 (2008). source
May combine two claims.
PremisecitationGelatin is an RGD-containing biopolymer derived from denatured collagen that improves scaffold binding to cells and biomolecules such as fibronectin.
“while gelatin was chosen as an RGD-containing biopolymer derived from denatured collagen that improves scaffold binding to cells and biomolecules such as fibronectin47,48.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [47] Ruoslahti, E. RGD and other recognition sequences for integrins. Annu Rev. Cell Dev. Biol. 12, 697–715 (1996). source
- cites [48] Katagiri, Y., Brew, S. A. & Ingham, K. C. All six modules of the gelatin-binding domain of fibronectin are required for full affinity. J. Biol. Chem. 278, 11897–11902 (2003). source
May combine two claims.
Interpretationown dataThese preliminary results suggest that scaffolds support functional myocardial tissue production using relatively small numbers of seeded hiPSC that can subsequently be cultured for extended time periods.
“These preliminary results suggest that our scaffolds support functional myocardial tissue production using relatively small numbers of seeded hiPSC that can subsequently be cultured for extended time periods.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningUse of conductance catheters was advantageous for direct volume readouts, but electrical pacing during catheterization was not recommended by the catheter manufacturer and therefore not performed.
“Our use of conductance catheters was advantageous for direct volume readouts but electrical pacing during catheterization was not recommended by the catheter manufacturer and therefore not performed in these studies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll animal procedures were approved by the Harvard Animal Care and Use Committee.
“All procedures were approved by the Harvard Animal Care and Use Committee”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationcitationIncluding a nanofibrous component to printable inks would be advantageous for directing cardiomyocyte shape and assembly in printed scaffolds or tissues.
“Our work suggests that including a nanofibrous component to printable inks would be advantageous for directing cardiomyocyte shape and assembly in printed scaffolds or tissues.”
Quote in the paperNot a substantial claim
The authors state this as an assumption.
The scale-model ventricle would have a diastolic chamber volume of about 500 microliters, about twice that of a rat and about 1/250 that of a human.
“We would build a scale-model of the human left ventricle chamber with diastolic chamber volume ~500 microliters (~2 × rat, ~1/250 human)”
The authors state this as an assumption.
The ventricle wall would not be vascularized and its thickness would be limited to about 0.1 mm to maintain high cell viability in a diffusion-limited environment.
“the ventricle wall would not be vascularized and its thickness limited to ~0.1 mm (~1/10 rat, ~1/100 human) to maintain high cell viability within the diffusion-limited environment”
The authors state this as an assumption.
The ventricle scaffold material would be a well-known protein-polymer mixture to ensure production reproducibility using existing nanofiber systems.
“the ventricle scaffold material would be a well-known protein-polymer mixture to ensure production reproducibility using existing nanofiber systems”
The authors state this as an assumption.
Cardiomyocyte alignment would be circumferential throughout the scaffold, representing a thin-walled approximation of the helical alignment within the native ventricular wall.
“cardiomyocyte alignment would be circumferential throughout the scaffold, representing a thin walled approximation of the helical alignment within the native ventricular wall.”
The paper relies on this without support.
The rat is the current industry standard for studying heart disease in vitro and in vivo.
“rat is the current industry standard for the study of heart disease in vitro and in vivo”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MacQueen et al. only cultivated pure cardiomyocytes within 14 days after seeding.
“However, they only cultivated pure cardiomyocytes within 14 days after seeding.”
From Engineered in vitro multi-cell type ventricle model generates long-term pulsatile flow and modulates cardiac output in response to cardioactive drugs (2025) · cites this paper as [20]
The Tissue-engineered ventricle chamber section says experiments were conducted 14 days after seeding, not that culture was limited to 14 days. The Discussion explicitly reports culturing a hiPSC-derived cardiomyocyte line in ventricle scaffolds for six months, contrary to the claim’s ‘only’ 14-day limit. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe hiPSC-CM based ventricular volumetric change between peak contraction and peak relaxation was 5.94 ± 1.66 % (n = 4), which is 2~5 and 8~20 times higher than values previously reported as ejection fraction for NRVM and hiPSC-CM in vitro ventricle models.
“We calculated our hiPSC-CM based ventricular volumetric change between peak contraction and peak relaxation to be 5.94 ± 1.66 % (n = 4, mean ± SEM, Fig. 4g), which is 2~5 and 8~20 times higher than values previously reported (ejection fraction) for NRVM and hiPSC-CM in vitro ventricle models, respectively13, 15, 32.”
From Fibre-infused gel scaffolds guide cardiomyocyte alignment in 3D-printed ventricles (2023) · cites this paper as [13]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredThese volume-handling models are limited to a single ventricle and lack perfusion capacity.
“However, these tissues are limited to a single ventricle model and thus lack the capacity for perfusion.”
From In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid (2020) · cites this paper as [7]
The Model assumptions section describes a single left-ventricle model with an unvascularized wall, supporting the lack of vascular tissue perfusion. But the Bioreactor section reports fluid flow through the ventricle and demonstrates assisted, valve-directed pumping. The paper therefore does not support the broader claim that a single-ventricle model lacks perfusion capacity altogether. (LLM, conf=0.85)
Experimental — accuracy not yet measuredThe thinnest hChaMP walls match prior literature values, while the thickest walls greatly exceed existing tissue models.
“Wall thicknesses on the low end of this spectrum match what has been previously demonstrated in the literature, and the high end of the spectrum far exceeds existing tissue models6–8.”
From In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid (2020) · cites this paper as [7]
In “Model assumptions for tissue-engineered ventricle chambers” (page unavailable), MacQueen et al. describe a tissue-engineered ventricle designed with a wall thickness limited to approximately 0.1 mm, providing a prior thin-wall benchmark. The paper does not establish that the thickest hChaMP walls exceed existing tissue models, so it supports only the low-end comparison. (LLM, conf=0.76)
Experimental — accuracy not yet measuredEngineered cardiac chambers enable physiologically relevant pressure-volume measurements and capture both contractile and diastolic dynamics that mimic aspects of native cardiac hemodynamics.
“Engineered cardiac chambers have emerged to address this gap, enabling physiologically relevant pressure-volume measurements and capturing both contractile and diastolic dynamics that mimic aspects of native cardiac hemodynamics.”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
The ‘Intra-ventricular pressure and volume measurements’ section reports catheter-based pressure–volume loops and contractile responses in engineered ventricles. The Discussion says the loops resemble those seen in severe valvular insufficiency, but it does not establish native-like diastolic dynamics; it also reports ejection fractions far below those of healthy ventricles. The claim overstates how closely the measured dynamics mimic native cardiac hemodynamics. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Michas et al. and MacQueen et al. successfully incorporated valves into microfluidic and bioreactor platforms, respectively.
“In contrast, Michas et al. and Macqueen et al. successfully incorporated valves into microfluidic and bioreactor platforms, respectively, with Michas et al. demonstrating unidirectional flow and MacQueen et al. reporting improved PV loop morphology as a result of valve presence (Michas et al., 2022; MacQueen et al., 2018).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
The section ‘Bioreactor for modular assembly of ventricles and valves’ (page unavailable) says MacQueen et al. built a bioreactor with valve inserts and demonstrated pumping with silicone tricuspid valves. It says PV loops could be acquired with or without valves, but does not report improved PV-loop morphology caused by valve presence. This verdict addresses MacQueen et al.’s portion of the sentence, not the separately cited Michas et al. study. (LLM, conf=0.86)
Experimental — accuracy not yet measuredMacQueen et al. described a structural arrhythmia model induced by cryoinjury, producing pinned spiral wave patterns consistent with clinical arrhythmia phenotypes.
“An additional disease model, a structural arrhythmia model induced by cryoinjury, was described by MacQueen et al. (2018). This approach produced pinned spiral wave patterns that are consistent with clinical arrhythmia phenotypes.”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
The Structural arrhythmia disease model section reports spiral waves pinned to anatomical defects and links anchored spiral waves to ventricular tachycardia. However, the Methods (Optical mapping experiments) say the defects were made by perforating the engineered ventricle with a biopsy punch, not by cryoinjury. (LLM, conf=0.90)
Experimental — accuracy not yet measuredECCs are exposed to multiaxial stress.
“These models more closely resemble the structural architecture of the heart, pump fluid, allow for analysis of Pressure-Volume (PV) readouts, facilitate control of preload and afterload, and are exposed to multiaxial stress (Li et al., 2018; MacQueen et al., 2018).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
The Methods section on scaffold analysis reports biaxial tensile testing of flat nanofibrous sheets made under the same conditions as the ventricle scaffolds. The paper also reports contraction and pressure changes in engineered ventricles, but it does not establish that the functioning chambers or their cells were exposed to multiaxial stress. (LLM, conf=0.79)
Experimental — accuracy not yet measuredMacQueen et al. reported improved PV loop morphology as a result of valve presence.
“In contrast, Michas et al. and Macqueen et al. successfully incorporated valves into microfluidic and bioreactor platforms, respectively, with Michas et al. demonstrating unidirectional flow and MacQueen et al. reporting improved PV loop morphology as a result of valve presence (Michas et al., 2022; MacQueen et al., 2018).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
The ‘Bioreactor for modular assembly of ventricles and valves’ section reports valve inserts and PV loops acquired with and without valves. The Discussion describes elliptical PV loops in the absence of valves, but our copy does not report that adding valves improved PV-loop morphology. Page numbers were not available in the supplied passages. (LLM, conf=0.85)
Experimental — accuracy not yet measuredECCs facilitate control of preload and afterload.
“These models more closely resemble the structural architecture of the heart, pump fluid, allow for analysis of Pressure-Volume (PV) readouts, facilitate control of preload and afterload, and are exposed to multiaxial stress (Li et al., 2018; MacQueen et al., 2018).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
The ‘Bioreactor for modular assembly of ventricles and valves’ section describes programmable pressure control, intra- and extra-ventricular flow loops, and optional valves. This supports control over some loading conditions, but the paper does not establish that preload and afterload can each be controlled. (LLM, conf=0.79)
Experimental — accuracy not yet measuredSelect models have incorporated functional valves, producing more physiological PV loops.
“Anatomically, select models have incorporated functional valves, producing more physiological PV loops (MacQueen et al., 2018; Michas et al., 2022).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
The ‘Bioreactor for modular assembly of ventricles and valves’ section reports functional silicone valves directing flow and says PV loops can be acquired with or without valves (Fig. 4). The Discussion describes valveless loops as resembling those seen with severe valvular insufficiency, but our copy does not report that adding valves produced more physiological PV loops. (LLM, conf=0.82)
Experimental — accuracy not yet measuredSimultaneous PV measurements are currently limited to invasive micro-catheter systems adapted from in vivo mouse experiments.
“Simultaneous PV measurements are currently limited to invasive micro-catheter systems adapted from in vivo mouse experiments (Li et al., 2018; MacQueen et al., 2018; Kupfer et al., 2020; Mohammadi et al., 2022).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
The Methods section on Pressure-Volume Measurements reports simultaneous pressure and volume measurements using catheters inserted into engineered ventricles, and says the system was designed and optimized for murine myocardium. It does not establish that simultaneous PV measurement is limited to invasive micro-catheter systems, and it identifies the catheters used here as rat PV catheters rather than specifically as systems adapted from in vivo mouse experiments. No page number is available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measuredThe rigidity and non-degradable nature of scaffolds in scaffold-based ventricles hampered cellular self-organization and matrix self-determination, preventing cohesive tissue formation and impairing cardiomyocyte contractility.
“While this scaffold-based approach facilitated enhanced CM orientation, the rigidity and non-degradable nature of the scaffolds hampered cellular self-organization and matrix self-determination, preventing the cells from forming a cohesive tissue and impairing the full potential contractility of the cardiomyocytes.”
From A human engineered mini-heart platform for mimicking ventricular pump function (2025) · cites this paper as Macqueen et al., 2018
The Discussion (page unavailable) says the scaffold was stiffer than healthy ventricular ECM and may have limited cardiomyocyte shortening; it also reports incomplete cardiomyocyte coverage. But the Ventricle scaffold section calls the material biodegradable and describes it as guiding cell assembly, not preventing cohesive tissue formation. The paper does not establish that scaffold rigidity or degradation properties hampered cellular self-organization or matrix self-determination. (LLM, conf=0.88)
Experimental — accuracy not yet measuredValve-less engineered cardiac chambers exhibit less distinct delays between pressure and volume fluctuations during beating cycles, typically leading to narrower, elliptical PV-loop patterns.
“In contrast, valve-less engineered cardiac chambers exhibit less distinct delays between pressure and volume fluctuations during beating cycles, typically leading to narrower, elliptical PV-loop patterns (R. A. Li et al., 2018;Macqueen et al., 2018).”
From A human engineered mini-heart platform for mimicking ventricular pump function (2025) · cites this paper as Macqueen et al., 2018
The Discussion reports elliptical pressure–volume loops in engineered chambers and says this shape is expected when ventricles contract without valves. It does not report less distinct delays between pressure and volume fluctuations or describe the loops as narrower; the pressure–volume measurements section gives amplitudes but no comparison of timing or loop width. Page numbers are unavailable in our copy. (LLM, conf=0.87)
Experimental — accuracy not yet measuredWhile there are a few models that can effectively mimic the pumping function of the heart, they are typically associated with significant cost and labor intensity.
“While there are a few models that can effectively mimic the pumping function of the heart, they are typically associated with significant cost and labor intensity.[ 19 , 20 ]”
From Engineered in vitro multi-cell type ventricle model generates long-term pulsatile flow and modulates cardiac output in response to cardioactive drugs (2025) · cites this paper as [20]
The Introduction (page unavailable) says animal models used to measure ventricular pressure and volume have high maintenance costs and low experimental throughput. That supports the cost concern, but the paper does not say that models mimicking the heart’s pumping function are typically labor-intensive. Its Discussion (page unavailable) also reports that the engineered ventricles’ contractile performance was far below that of healthy ventricles. (LLM, conf=0.82)
Experimental — accuracy not yet measuredThe frequency increase after 10 μM ISO treatment in our measurements was 30.6 to 45.9%, which confirms data showing an increase of around 88% reported by Hamad et al. and around 15% reported by MacQueen et al.
“Starting with the frequency changes, we can confirm data showing an increase of around 88% after 10 µM ISO treatment reported by Hamad et al.[ 17 ] and around 15 % reported by MacQueen et al.,[ 20 ] with measurements showing an increase of 30.6 to 45.9%.”
From Engineered in vitro multi-cell type ventricle model generates long-term pulsatile flow and modulates cardiac output in response to cardioactive drugs (2025) · cites this paper as [20]
The Intra-ventricular pressure and volume measurements section reports that isoproterenol increased beat frequency in engineered ventricles. It gives an approximately 40% increase at 100 µM, however, and does not report an approximately 15% increase at the cited 10 µM dose. No page number is available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measuredThe mean beating frequency in MacQueen et al.'s model was about 85 bpm, comparable to our engineered ventricles.
“The mean beating frequency in their model was about 85 bpm,[ 20 ] which is comparable to our engineered ventricles.”
From Engineered in vitro multi-cell type ventricle model generates long-term pulsatile flow and modulates cardiac output in response to cardioactive drugs (2025) · cites this paper as [20]
The Intra-ventricular pressure and volume measurements section reports a spontaneous beat rate of about 85 ± 15 bpm for the human hiPSC-CM ventricles. It reports about 130 ± 15 bpm for the rat NRVM ventricles, so 85 bpm does not describe MacQueen et al.’s models generally. The comparison with the citing authors’ ventricles is their own assessment, not a finding attributed to this source. (LLM, conf=0.87)
Experimental — accuracy not yet measuredMacQueen et al. generated a ventricle model by seeding human cardiomyocytes onto an electrospun ventricle scaffold and measured a volume change during a contraction cycle of approximately 0.4 μL.
“MacQueen et al. generated a ventricle model by seeding human cardiomyocytes onto an electrospun ventricle scaffold and measured a volume change during a contraction cycle of approximately 0.4 µL.[ 20 ]”
From Engineered in vitro multi-cell type ventricle model generates long-term pulsatile flow and modulates cardiac output in response to cardioactive drugs (2025) · cites this paper as [20]
The Introduction and Tissue-engineered ventricle chamber section describe seeding ventricle-shaped nanofibrous scaffolds with human induced pluripotent stem cell-derived cardiomyocytes. However, the Intra-ventricular pressure and volume measurements section (Fig. 3b) reports a volume change of approximately 1 µL per contraction cycle for the human-cell ventricles, not 0.4 µL. (LLM, conf=0.92)
Experimental — accuracy not yet measuredFiber-spinning techniques can reproduce fine spatial features with higher throughputs and have been used to engineer tissue scaffolds such as heart valves and ventricle models.
“Because fiber-spinning techniques can reproduce these fine spatial features with higher throughputs, they offer a potential solution and have been used previously to engineer tissue scaffolds, such as heart valves (23) and ventricle models (24).”
From Recreating the heart's helical structure-function relationship with focused rotary jet spinning (2022) · cites this paper as [24]
These conduction velocity values were consistent with previous reports of in vitro tissues composed of immature cardiomyocytes, where factors such as geometry, calcium handling, and gap junction expression can influence CV.
“These values were consistent with previous reports of in vitro tissues composed of immature cardiomyocytes, where factors such as geometry, calcium handling, and gap junction expression can influence CV (24, 34, 35).”
From Recreating the heart's helical structure-function relationship with focused rotary jet spinning (2022) · cites this paper as [24]
The metrics presented (e.g., EF) were greater by a factor of ~3 than recently reported in vitro ventricle models but still substantially lower than in vivo values.
“Although the metrics presented here (e.g., EF) were greater (by a factor of ~3) than for recently reported in vitro ventricle models (24, 39), they were still substantially lower than in vivo values (tables S2 and S3).”
From Recreating the heart's helical structure-function relationship with focused rotary jet spinning (2022) · cites this paper as [24]
Existing single ventricle models use simple cup-like geometry for casting cardiomyocyte-laden gel or seeding cardiomyocytes after fabrication.
“Indeed, multiple existing single ventricle models rely on their simple cup-like geometry to enable casting of a cardiomyocyte-laden gel6 or seeding of cardiomyocytes after fabrication7.”
From In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid (2020) · cites this paper as [7]
Researchers have generated volume-handling cardiac tissue models that recapitulate pressure-volume dynamics of the heart.
“To address this issue, researchers have made strides in the generation of volume-handling cardiac tissue models capable of recapitulating pressure-volume dynamics of the heart6–8.”
From In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid (2020) · cites this paper as [7]
The hChaMP ejection fraction measurements are comparable to those reported for single ventricle models.
“These measurements are on par with data shown in single ventricle models6, 7.”
From In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid (2020) · cites this paper as [7]
The hChaMP maintained its functions for at least six weeks, whereas most comparable models have been characterized only up to two weeks after fabrication.
“Notably, we show that the hChaMP can maintain these functions for at least 6 weeks, while most similar models have been characterized only up to 2 weeks after fabrication6–8, 18.”
From In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid (2020) · cites this paper as [7]
Experimental — accuracy not yet measuredThe hChaMP responds to a range of isoproterenol doses, as also reported by MacQueen et al.
“similar to results reported by MacQueen et al., we show that the hChaMP can respond to a range of isoproterenol doses7.”
From In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid (2020) · cites this paper as [7]
The hChaMP generated a low pressure of 0.23 mmHg, which is higher than other reported values.
“the pressure generated by the hChaMP, while low (0.23 mmHg), is higher than other reported values6, 7.”
From In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid (2020) · cites this paper as [7]
3D Engineered Cardiac Chambers (ECCs) more closely resemble the structural architecture of the heart than other cardiac models.
“These models more closely resemble the structural architecture of the heart, pump fluid, allow for analysis of Pressure-Volume (PV) readouts, facilitate control of preload and afterload, and are exposed to multiaxial stress (Li et al., 2018; MacQueen et al., 2018).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
ECCs pump fluid.
“These models more closely resemble the structural architecture of the heart, pump fluid, allow for analysis of Pressure-Volume (PV) readouts, facilitate control of preload and afterload, and are exposed to multiaxial stress (Li et al., 2018; MacQueen et al., 2018).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
Incorporation of valves is critical for reproducing physiologic PV loops and ensuring unidirectional flow.
“Incorporation of valves is critical for reproducing physiologic PV loops and ensuring unidirectional flow (MacQueen et al., 2018; Michas et al., 2022).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
ECCs allow for analysis of Pressure-Volume (PV) readouts.
“These models more closely resemble the structural architecture of the heart, pump fluid, allow for analysis of Pressure-Volume (PV) readouts, facilitate control of preload and afterload, and are exposed to multiaxial stress (Li et al., 2018; MacQueen et al., 2018).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
Current fabrication approaches for engineered ventricular chambers, including molding, scaffold-seeding, and bioprinting, have significant limitations.
“However, current fabrication approaches used to create these engineered ventricular chambers, including molding (R. A. Li et al., 2018), scaffold-seeding (Macqueen et al., 2018;Michas et al., 2022;Mohammadi et al., 2022;Patel & Birla, 2018) and bioprinting (Kupfer et al., 2020;Lee et al., n.d.) have significant limitations that hamper their use.”
From A human engineered mini-heart platform for mimicking ventricular pump function (2025) · cites this paper as Macqueen et al., 2018
Functional characterization of current engineered ventricles is often done utilizing conductance catheters, which come with high costs, low accessibility and incompatibility with electrical pacing.
“Furthermore, functional characterization of current engineered ventricles is often done utilizing conductance catheters (Kupfer et al., 2020;R. A. Li et al., 2018;Macqueen et al., 2018), which come with high costs, low accessibility and incompatibility with electrical pacing (Baan et al., 1985;Wei et al., 2014).”
From A human engineered mini-heart platform for mimicking ventricular pump function (2025) · cites this paper as Macqueen et al., 2018
Although far from human ejection fraction values (50%-70%), the ejection fractions of our mini-heart (~1%-3%) are in the same range as other reported models (0.2%-9.6%).
“Although far from human ejection fraction values (50%-70%), the ejection fractions of our mini-heart (~1%-3%) are in the same range as other reported models (0.2%-9.6%) (Kupfer et al., 2020;R. A. Li et al., 2018;Macqueen et al., 2018;Michas et al., 2022).”
From A human engineered mini-heart platform for mimicking ventricular pump function (2025) · cites this paper as Macqueen et al., 2018
The observed negative force-frequency relationship is consistent with findings in similar models and suggests the calcium handling of hPSC-CMs still requires further maturation.
“However, the observed negative force-frequency relationship is consistent with findings in similar models (R. A. Li et al., 2018;Macqueen et al., 2018) and suggests the calcium handling of hPSC-CMs still requires further maturation.”
From A human engineered mini-heart platform for mimicking ventricular pump function (2025) · cites this paper as Macqueen et al., 2018
The mini-hearts demonstrated stroke works of ~0.10 -~0.18 μJ, which are the highest stroke work values compared to other engineered ventricles (6 nJ-57 nJ).
“The mini-hearts demonstrated stroke works of ~0.10 -~0.18 µJ which, to our knowledge, are the highest stroke work values compared to other engineered ventricles (6 nJ-57 nJ) (Kupfer et al., 2020;R. A. Li et al., 2018;Macqueen et al., 2018).”
From A human engineered mini-heart platform for mimicking ventricular pump function (2025) · cites this paper as Macqueen et al., 2018
Introduction of electrical barriers such as holes in healthy cardiac tissue or fibroblast dense regions disrupts action potential propagation.
“Recent examples have also demonstrated that the introduction of electrical barriers such as holes in healthy cardiac tissue or fibroblast dense regions disrupts action potential propagation46,52.”
From 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels (2021) · cites this paper as [52]
Cites
Methods of Theoretical Physics
Morse, P. M., Feshbach, H., & Hill, E. L. (1954) · American Journal of Physics · doi:10.1119/1.1933765 · Cited by 13,197 · see citing works
Akselrod, S., Gordon, D., Ubel, F. A., Shannon, D. C., Berger, A. C., & Cohen, R. J. (1981) · Science · doi:10.1126/science.6166045 · Cited by 5,079 · see citing works
Organoid Models and Applications in Biomedical Research
Xinaris, C., Brizi, V., & Remuzzi, G. (2015) · The Nephron journals/Nephron journals · doi:10.1159/000433566 · Cited by 3,517 · see citing works
RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191 · see citing works
Sydney Gladman, A., Matsumoto, E. A., Nuzzo, R. G., Mahadevan, L., & Lewis, J. A. (2016) · Nature Materials · doi:10.1038/nmat4544 · Cited by 3,027 · see citing works
Self-citationAdvanced maturation of human cardiac tissue grown from pluripotent stem cells
Ronaldson-Bouchard, K., Ma, S. P., Yeager, K., Chen, T., Song, L., Sirabella, D., Morikawa, K., Teles, D., Yazawa, M., & Vunjak-Novakovic, G. (2018) · Nature · doi:10.1038/s41586-018-0016-3 · Cited by 1,272 · see citing works
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251 · see citing works
Basic Mechanisms of Cardiac Impulse Propagation and Associated Arrhythmias
KLÉBER, A. G., & RUDY, Y. (2004) · Physiological Reviews · doi:10.1152/physrev.00025.2003 · Cited by 1,083 · see citing works
Vascularization is the key challenge in tissue engineering
Novosel, E. C., Kleinhans, C., & Kluger, P. J. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.03.004 · Cited by 1,067 · see citing works
Biowire: a platform for maturation of human pluripotent stem cell–derived cardiomyocytes
Nunes, S. S., Miklas, J. W., Liu, J., Aschar-Sobbi, R., Xiao, Y., Zhang, B., Jiang, J., Massé, S., Gagliardi, M., Hsieh, A., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2524 · Cited by 952 · see citing works
Engineering Adolescence: Maturation of Human Pluripotent Stem Cell–Derived Cardiomyocytes
Yang, X., Pabon, L., & Murry, C. E. (2014) · Circulation Research · doi:10.1161/circresaha.114.300558 · Cited by 939 · see citing works
Continuous measurement of left ventricular volume in animals and humans by conductance catheter.
Baan, J., van der Velde, E. T., de Bruin, H. G., Smeenk, G. J., Koops, J., van Dijk, A. D., Temmerman, D., Senden, J. M., & Buis, B. (1984) · Circulation · doi:10.1161/01.cir.70.5.812 · Cited by 899 · see citing works
Instrumented cardiac microphysiological devices via multimaterial three-dimensional printing
Lind, J. U., Busbee, T. A., Valentine, A. D., Pasqualini, F. S., Yuan, H., Yadid, M., Park, S.-J., Kotikian, A., Nesmith, A. P., Campbell, P. H., et al. (2017) · Nature Materials · doi:10.1038/nmat4782 · Cited by 863 · see citing works
Self-citationWang, G., McCain, M. L., Yang, L., He, A., Pasqualini, F. S., Agarwal, A., Yuan, H., Jiang, D., Zhang, D., Zangi, L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3545 · Cited by 837 · see citing works
Self-citationBurkhoff, D., MIRSKY, I., & Suga, H. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00138.2005 · Cited by 767 · see citing works
Muscular Thin Films for Building Actuators and Powering Devices
Feinberg, A. W., Feigel, A., Shevkoplyas, S. S., Sheehy, S., Whitesides, G. M., & Parker, K. K. (2007) · Science · doi:10.1126/science.1146885 · Cited by 765 · see citing works
Self-citationPacher, P., Nagayama, T., Mukhopadhyay, P., Bátkai, S., & Kass, D. A. (2008) · Nature Protocols · doi:10.1038/nprot.2008.138 · Cited by 734 · see citing works
Phototactic guidance of a tissue-engineered soft-robotic ray
Park, S., Gazzola, M., Park, K. S., Park, S., Santo, V. D., Blevins, E. L., Lind, J. U., Campbell, P. H., Dauth, S., Capulli, A. K., et al. (2016) · Science · doi:10.1126/science.aaf4292 · Cited by 717 · see citing works
Self-citationTiburcy, M., Hudson, J. E., Balfanz, P., Schlick, S. F., Meyer, T., Liao, M.-L. C., Levent, E., Raad, F. S., Zeidler, S., Wingender, E., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024145 · Cited by 649 · see citing works
Electrospun fine-textured scaffolds for heart tissue constructs
Zong, X., Bien, H., Chung, C.-Y., Yin, L., Fang, D., Hsiao, B. S., Chu, B., & Entcheva, E. G. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.01.052 · Cited by 643 · see citing works
Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs
Kim, D.-H., Lipke, E. A., Kim, P., Cheong, R., Thompson, S., Delannoy, M., Suh, K.-Y., Tung, L., & Levchenko, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906504107 · Cited by 611 · see citing works
Engineered In Vitro Disease Models
Benam, K. H., Dauth, S., Hassell, B., Herland, A., Jain, A., Jang, K.-J., Karalis, K., Kim, H. J., MacQueen, L., Mahmoodian, R., et al. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040418 · Cited by 554 · see citing works
Self-citationHuman iPSC-based Cardiac Microphysiological System For Drug Screening Applications
Mathur, A., Loskill, P., Shao, K., Huebsch, N., Hong, S., Marcus, S. G., Marks, N. C., Mandegar, M. A., Conklin, B. R., Lee, L. P., et al. (2015) · Scientific Reports · doi:10.1038/srep08883 · Cited by 527 · see citing works
CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs
Mandegar, M. A., Huebsch, N., Frolov, E. B., Shin, E., Truong, A., Olvera, M. P., Chan, A. H., Miyaoka, Y., Holmes, K., Spencer, C. I., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.01.022 · Cited by 525 · see citing works
Karakikes, I., Ameen, M., Termglinchan, V., & Wu, J. C. (2015) · Circulation Research · doi:10.1161/circresaha.117.305365 · Cited by 478 · see citing works
Simpson, P., & Savion, S. (1982) · Circulation Research · doi:10.1161/01.res.50.1.101 · Cited by 453 · see citing works
Boudou, T., Legant, W. R., Mu, A., Borochin, M. A., Thavandiran, N., Radisic, M., Zandstra, P. W., Epstein, J. A., Margulies, K. B., & Chen, C. S. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0341 · Cited by 413 · see citing works
Human Engineered Heart Tissue: Analysis of Contractile Force
Mannhardt, I., Breckwoldt, K., Letuffe-Brenière, D., Schaaf, S., Schulz, H., Neuber, C., Benzin, A., Werner, T., Eder, A., Schulze, T., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.04.011 · Cited by 398 · see citing works
Bioengineering human myocardium on native extracellular matrix
Guyette, J. P., Charest, J. M., Mills, R. W., Jank, B. J., Moser, P. T., Gilpin, S. E., Gershlak, J. R., Okamoto, T., Gonzalez, G., Milan, D. J., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.306874 · Cited by 343 · see citing works
Self-citationLaminar fiber architecture and three-dimensional systolic mechanics in canine ventricular myocardium
Costa, K. D., Takayama, Y., McCulloch, A. D., & Covell, J. W. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.2.h595 · Cited by 313 · see citing works
Baan, J., JONG, T. T. A., Kerkhof, P. L. M., et al. (1981) · Cardiovascular Research · doi:10.1093/cvr/15.6.328 · Cited by 300 · see citing works
Kai, D., Prabhakaran, M. P., Jin, G., & Ramakrishna, S. (2011) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.31862 · Cited by 288 · see citing works
Design and formulation of functional pluripotent stem cell-derived cardiac microtissues
Thavandiran, N., Dubois, N., Mikryukov, A., Massé, S., Beca, B., Simmons, C. A., Deshpande, V. S., McGarry, J. P., Chen, C. S., Nanthakumar, K., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311120110 · Cited by 285 · see citing works
Rohr, S., Kucera, J. P., & Kléber, A. G. (1998) · Circulation Research · doi:10.1161/01.res.83.8.781 · Cited by 271 · see citing works
Cardiomyocyte Cultures With Controlled Macroscopic Anisotropy
Bursac, N., Parker, K. K., Iravanian, S., & Tung, L. (2002) · Circulation Research · doi:10.1161/01.res.0000047530.88338.eb · Cited by 268 · see citing works
Self-citationEndoh, M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.013 · Cited by 250 · see citing works
Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues
Feric, N. T., & Radisic, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.04.019 · Cited by 247 · see citing works
Controlling the contractile strength of engineered cardiac muscle by hierarchal tissue architecture
Feinberg, A. W., Alford, P. W., Jin, H., Ripplinger, C. M., Werdich, A. A., Sheehy, S. P., Grosberg, A., & Parker, K. K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.043 · Cited by 240 · see citing works
Self-citationMiniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses
Huebsch, N., Loskill, P., Deveshwar, N., Spencer, C. I., Judge, L. M., Mandegar, M. A., Fox, C. B., Mohamed, T., Ma, Z., Mathur, A., et al. (2016) · Scientific Reports · doi:10.1038/srep24726 · Cited by 227 · see citing works
Processing and analysis of cardiac optical mapping data obtained with potentiometric dyes
Laughner, J. I., Ng, F. S., Sulkin, M. S., et al. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00404.2012 · Cited by 218 · see citing works
Rohr, S., Schölly, D. M., & Kléber, A. G. (1991) · Circulation Research · doi:10.1161/01.res.68.1.114 · Cited by 218 · see citing works
Mauck, R. L., Baker, B. M., Nerurkar, N. L., Burdick, J. A., Li, W.-J., Tuan, R. S., & Elliott, D. M. (2009) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2008.0652 · Cited by 213 · see citing works
Three-dimensional transmural organization of perimysial collagen in the heart
Pope, A. J., Sands, G. B., Smaill, B. H., & LeGrice, I. J. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00484.2008 · Cited by 205 · see citing works
Human engineered heart tissue as a model system for drug testing
Eder, A., Vollert, I., Hansen, A., & Eschenhagen, T. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.010 · Cited by 190 · see citing works
In vitro cardiac tissue models: Current status and future prospects
Mathur, A., Ma, Z., Loskill, P., Jeeawoody, S., & Healy, K. E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.011 · Cited by 187 · see citing works
Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium
Turnbull, I. C., Karakikes, I., Serrao, G. W., Backeris, P., Lee, J., Xie, C., Senyei, G., Gordon, R. E., Li, R. A., Akar, F. G., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-228007 · Cited by 184 · see citing works
Li, R. A., Keung, W., Cashman, T. J., Backeris, P. C., Johnson, B. V., Bardot, E. S., Wong, A. O. T., Chan, P. K. W., Chan, C. W. Y., & Costa, K. D. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.024 · Cited by 175 · see citing works
Relating myocardial laminar architecture to shear strain and muscle fiber orientation
Arts, T., Costa, K. D., Covell, J. W., & McCulloch, A. D. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.5.h2222 · Cited by 172 · see citing works
Electrospun nanofibers as a tool for architecture control in engineered cardiac tissue
Orlova, Y., Magome, N., Liu, L., Chen, Y., & Игоревич, А. К. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.042 · Cited by 171 · see citing works
Passive Stiffness of Myocardium From Congenital Heart Disease and Implications for Diastole
Chaturvedi, R. R., Herron, T., Simmons, R., Shore, D., Kumar, P., Sethia, B., Chua, F., Vassiliadis, E., & Kentish, J. C. (2010) · Circulation · doi:10.1161/circulationaha.109.850677 · Cited by 167 · see citing works
Distilling complexity to advance cardiac tissue engineering
Ogle, B. M., Bursac, N., Domian, I. J., Huang, N. F., Menasché, P., Murry, C. E., Pruitt, B. L., Radisic, M., Wu, J. C., Wu, S. M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad2304 · Cited by 163 · see citing works
Tzatzalos, E., Abilez, O. J., Shukla, P., & Wu, J. C. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.010 · Cited by 162 · see citing works
Germanguz, I., Sedan, O., Zeevi‐Levin, N., Shtrichman, R., Barak, E., Ziskind, A., Eliyahu, S., Meiry, G., Amit, M., Itskovitz‐Eldor, J., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00996.x · Cited by 160 · see citing works
Physiologic force-frequency response in engineered heart muscle by electromechanical stimulation
Godier-Furnémont, A., Tiburcy, M., Wagner, E., Dewenter, M., Lämmle, S., El‐Armouche, A., Lehnart, S. E., Vunjak‐Novakovic, G., & Zimmermann, W. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.03.055 · Cited by 157 · see citing works
Comparative chronotropic activity of β‐adrenoceptive antagonists
BARRETT, A. M., & CARTER, J. (1970) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1970.tb10619.x · Cited by 156 · see citing works
New approaches in small animal echocardiography: imaging the sounds of silence
Ram, R., Mickelsen, D. M., Theodoropoulos, C., & Blaxall, B. C. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00559.2011 · Cited by 142 · see citing works
Fibrous scaffolds for building hearts and heart parts
Capulli, A. K., MacQueen, L. A., Sheehy, S. P., & Parker, K. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.020 · Cited by 130 · see citing works
Self-citationSidorov, V. Y., Samson, P. C., Sidorova, T. N., Davidson, J. M., Lim, C. C., & Wikswo, J. P. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.11.009 · Cited by 127 · see citing works
Spiral Wave Attachment to Millimeter-Sized Obstacles
Lim, Z. Y., Maskara, B., Aguel, F., Emokpae, R., & Tung, L. (2006) · Circulation · doi:10.1161/circulationaha.105.598631 · Cited by 117 · see citing works
Structural Phenotyping of Stem Cell-Derived Cardiomyocytes
Pasqualini, F. S., Sheehy, S. P., Agarwal, A., Aratyn-Schaus, Y., & Parker, K. K. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.01.020 · Cited by 101 · see citing works
Self-citationDevelopment of a Biological Ventricular Assist Device: Preliminary Data From a Small Animal Model
Yildirim, Y., Naito, H., Didié, M., Karikkineth, B. C., Biermann, D., Eschenhagen, T., & Zimmermann, W.-H. (2007) · Circulation · doi:10.1161/circulationaha.106.679688 · Cited by 100 · see citing works
The contribution of cellular mechanotransduction to cardiomyocyte form and function
Sheehy, S. P., Grosberg, A., & Parker, K. K. (2012) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-012-0419-2 · Cited by 87 · see citing works
Self-citationEngineered cardiac organoid chambers: toward a functional biological model ventricle
Lee, E. J., Kim, D. E., Azeloglu, E. U., & Costa, K. D. (2008) · Tissue Engineering Part A · doi:10.1089/tea.2007.0351 · Cited by 84 · see citing works
A 3D aligned microfibrous myocardial tissue construct cultured under transient perfusion
Kenar, H., Köse, G. T., Toner, M., Kaplan, D. L., & Hasırcı, V. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.025 · Cited by 83 · see citing works
Influence of age, growth, and sex on cardiac myocyte size and number in rats
Bai, S., Campbell, S. E., Moore, J. A., Morales, M. C., & Martin Gerdes, A. (1990) · The Anatomical Record · doi:10.1002/ar.1092260210 · Cited by 79 · see citing works
MEIRY, G., REISNER, Y., FELD, Y., GOLDBERG, S., ROSEN, M., ZIV, N., & BINAH, O. (2001) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2001.01269.x · Cited by 77 · see citing works
Brito‐Martins, M., Harding, S. E., & Ali, N. N. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707619 · Cited by 74 · see citing works
Electrical Conductivity and Permittivity of Murine Myocardium
Raghavan, K., Porterfield, J. E., Kottam, A. T. G., et al. (2009) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2009.2012401 · Cited by 71 · see citing works
Heart wall myofibers are arranged in minimal surfaces to optimize organ function
Savadjiev, P., Strijkers, G. J., Bakermans, A. J., Piuze, E., Zucker, S. W., & Siddiqi, K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120785109 · Cited by 62 · see citing works
Production of Synthetic, Para-Aramid and Biopolymer Nanofibers by Immersion Rotary Jet-Spinning
Gonzalez, G. M., MacQueen, L. A., Lind, J. U., Fitzgibbons, S. A., Chantre, C. O., Huggler, I., Golecki, H. M., Goss, J. A., & Parker, K. K. (2016) · Macromolecular Materials and Engineering · doi:10.1002/mame.201600365 · Cited by 61 · see citing works
Self-citationDesign and Fabrication of Fibrous Nanomaterials Using Pull Spinning
Deravi, L. F., Sinatra, N. R., Chantre, C. O., Nesmith, A. P., Yuan, H., Deravi, S. K., Goss, J. A., MacQueen, L. A., Badrossamy, M. R., Gonzalez, G. M., et al. (2017) · Macromolecular Materials and Engineering · doi:10.1002/mame.201600404 · Cited by 60 · see citing works
Self-citationControlling the Cellular Organization of Tissue‐Engineered Cardiac Constructs
GONEN‐WADMANY, M., GEPSTEIN, L., & SELIKTAR, D. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1302.025 · Cited by 56 · see citing works
Fenske, S., Pröbstle, R., Auer, F., Hassan, S., Marks, V., Pauža, D. H., Biel, M., & Wahl‐Schott, C. (2015) · Nature Protocols · doi:10.1038/nprot.2015.139 · Cited by 53 · see citing works
Quinn, K. P., Sullivan, K. E., Liu, Z., Ballard, Z., Siokatas, C., Georgakoudi, I., & Black, L. D. (2016) · Scientific Reports · doi:10.1038/srep35823 · Cited by 52 · see citing works
All Six Modules of the Gelatin-binding Domain of Fibronectin Are Required for Full Affinity
Katagiri, Y., Brew, S. A., & Ingham, K. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212512200 · Cited by 50 · see citing works
Strategies and Challenges to Myocardial Replacement Therapy
Feric, N. T., & Radisic, M. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0288 · Cited by 49 · see citing works
Small animal cardiovascular MR imaging and spectroscopy
Bakermans, A. J., Abdurrachim, D., Moonen, R. P. M., Motaal, A. G., Prompers, J. J., Strijkers, G. J., Vandoorne, K., & Nicolay, K. (2015) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2015.03.001 · Cited by 35 · see citing works
Myocardial tissue engineering for cardiac repair
Pecha, S., Eschenhagen, T., & Reichenspurner, H. C. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.12.007 · Cited by 26 · see citing works
Advancements in pressure–volume catheter technology – stress remodelling after infarction
Clark, J., & Marber, M. S. (2012) · Experimental Physiology · doi:10.1113/expphysiol.2012.064733 · Cited by 26 · see citing works
Arrhythmogenic and metabolic remodelling of failing human heart
Gloschat, C. R., Koppel, A. C., Aras, K. K., Brennan, J. A., Holzem, K. M., & Efimov, I. R. (2016) · The Journal of Physiology · doi:10.1113/jp271992 · Cited by 23 · see citing works
(2015) · PubMed · Cited by 23 · see citing works
Koglin, J., Böhm, M., von Scheidt, W., Stäblein, A., & Erdmann, E. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90754-4 · Cited by 21 · see citing works
Building a bioartificial heart: Obstacles and opportunities
Lundberg, M. S., Baldwin, J. T., & Buxton, D. B. (2017) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.10.103 · Cited by 18 · see citing works
Accuracy considerations in catheter based estimation of left ventricular volume
Pearce, J. A., Porterfield, J. E., Larson, E. R., Valvano, J. W., & Feldman, M. D. (2010) · 2010 Annual International Conference of the IEEE Engineering in Medicine and Biology · doi:10.1109/iembs.2010.5627712 · Cited by 6 · see citing works
Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes
Zimmermann, W. H., Fink, C., Kralisch, D., Remmers, U., Weil, J., & Eschenhagen, T. (2000) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(20000405)68:1
Flagged first, then by citations
Research works printed but not linked: 2
- Pacher, P., Nagayama, T., Mukhopadhyay, P., Batkai, S. & Kass, D. A. Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats. Nat. Protoc. 3, 1422–1434 (2008). · DOI · Paper page
- Klabunde, R. E. Cardiovascular Physiology Concepts 2nd edn (Lippincott Williams & Wilkins/Wolters Kluwer, Philadelphia, 2012).
Cited by
Sorted by citations
A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling
Zhao, Y., Rafatian, N., Feric, N. T., Cox, B. J., Aschar-Sobbi, R., Wang, E. Y., Aggarwal, P., Zhang, B., Conant, G., Ronaldson-Bouchard, K., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.042 · Cited by 610 · see citing works
“…(hPSC) have focused on generating ventricular myocardium (Ahn et al., 2018; Eschenhagen et al., 2012; Lemoine et al., 2017; Lind et al., 2017a; MacQueen et al., 2018; Nunes et al., 2013; Schaaf et al., 2011; Tulloch et al., 2011); (Lemoine et al., 2018; Lind et al., 2017b; Tiburcy et al.,…”
Daly, A. C., Davidson, M. D., & Burdick, J. A. (2021) · Nature Communications · doi:10.1038/s41467-021-21029-2 · Cited by 470 · see citing works
Kupfer, M. E., Lin, W.-H., Ravikumar, V., Qiu, K., Wang, L., Gao, L., Bhuiyan, D. B., Lenz, M., Ai, J., Mahutga, R. R., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.316155 · Cited by 329 · see citing works
Santos, D. M. D., Correa, D. S., Medeiros, E. S. D., de Oliveira, J. E., & Mattoso, L. H. C. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c12410 · Cited by 237 · see citing works
Cardiovascular disease models: A game changing paradigm in drug discovery and screening
Savoji, H., Mohammadi, M. H., Rafatian, N., Toroghi, M. K., Wang, E. Y., Zhao, Y., Korolj, A., Ahadian, S., & Radisic, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.036 · Cited by 223 · see citing works
Goldfracht, I., Efraim, Y., Shinnawi, R., Kovalev, E., Huber, I., Gepstein, A., Arbel, G., Shaheen, N., Tiburcy, M., Zimmermann, W. H., et al. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.016 · Cited by 222 · see citing works
Fibre-infused gel scaffolds guide cardiomyocyte alignment in 3D-printed ventricles
Choi, S., Lee, K. Y., Kim, S. L., MacQueen, L. A., Chang, H., Zimmerman, J. F., Jin, Q., Peters, M. M., Ardoña, H. A. M., Liu, X., et al. (2023) · Nature Materials · doi:10.1038/s41563-023-01611-3 · Cited by 212 · see citing works
Self-citationMuscle tissue engineering in fibrous gelatin: implications for meat analogs
MacQueen, L. A., Alver, C. G., Chantre, C. O., Ahn, S., Cera, L., Gonzalez, G. M., O’Connor, B. B., Drennan, D. J., Peters, M. M., Motta, S. E., et al. (2019) · npj Science of Food · doi:10.1038/s41538-019-0054-8 · Cited by 210 · see citing works
Self-citationWan, X., Zhao, Y., Li, Z., & Li, L. (2022) · Exploration · doi:10.1002/exp.20210029 · Cited by 188 · see citing works
Mastikhina, O., Moon, B., Williams, K., Hatkar, R., Gustafson, D., Mourad, O., Sun, X., Koo, M., Lam, A. Y. L., Sun, Y., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119741 · Cited by 190 · see citing works
Challenges and opportunities for the next generation of cardiovascular tissue engineering
Cho, S., Discher, D. E., Leong, K. W., Vunjak-Novakovic, G., & Wu, J. C. (2022) · Nature Methods · doi:10.1038/s41592-022-01591-3 · Cited by 176 · see citing works
Silva, A. C., Rubio, O., Joy, D. A., Kauss, M. A., Natarajan, V., Lai, M. H., Turaga, D., Blair, A. P., Alexanian, M., Bruneau, B. G., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.11.007 · Cited by 179 · see citing works
Fang, Y., Guo, Y., Wu, B., Liu, Z., Ye, M., Xu, Y., Ji, M., Chen, L., Lu, B., Nie, K., et al. (2023) · Advanced Materials · doi:10.1002/adma.202205082 · Cited by 155 · see citing works
Ahrens, J. H., Uzel, S. G. M., Skylar‐Scott, M., Mata, M. M., Lu, A., Kroll, K. T., & Lewis, J. A. (2022) · Advanced Materials · doi:10.1002/adma.202200217 · Cited by 143 · see citing works
Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering
Tenreiro, M. F., Louro, A. F., Alves, P. M., & Serra, M. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00140-4 · Cited by 145 · see citing works
Recreating the heart's helical structure-function relationship with focused rotary jet spinning
Chang, H., Liu, Q., Zimmerman, J. F., Lee, K. Y., Jin, Q., Peters, M. M., Rosnach, M., Choi, S., Kim, S. L., Ardoña, H. A. M., et al. (2022) · Science · doi:10.1126/science.abl6395 · Cited by 131 · see citing works
Self-citationBliley, J. M., Vermeer, M. C. S. C., Duffy, R. M., Batalov, I., Kramer, D., Tashman, J. W., Shiwarski, D. J., Lee, A. R., Teplenin, A. S., Volkers, L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd1817 · Cited by 134 · see citing works
Passive myocardial mechanical properties: meaning, measurement, models
Emig, R., Zgierski-Johnston, C., Timmermann, V., Taberner, A., Nash, M., Kohl, P., & Peyronnet, R. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00838-1 · Cited by 115 · see citing works
“The embryonic murine heart stiffens progressively, from < 1 kPa for the cardiac tube to 10 kPa in embryos aged E2 to E14 (Majkut et al. 2013, 2014; Chiou et al. 2016), as assessed by micropipette aspiration and computationally.”
BackgroundBiomaterializing the promise of cardiac tissue engineering
Pomeroy, J. E., Helfer, A., & Bursac, N. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.009 · Cited by 107 · see citing works
“A modified electrospinning method was also used to generate single ventricle human fECTs which the authors cultured in a specialized bioreactor that allowed for continuous hemodynamic monitoring (MacQueen et al., 2018).”
MethodCellular and Engineered Organoids for Cardiovascular Models
Thomas, D., Choi, S., Alamana, C., Parker, K. K., & Wu, J. C. (2022) · Circulation Research · doi:10.1161/circresaha.122.320305 · Cited by 95 · see citing works
Self-citationNative cardiac environment and its impact on engineering cardiac tissue
Schwach, V., & Passier, R. C. (2019) · Biomaterials Science · doi:10.1039/c8bm01348a · Cited by 92 · see citing works
Chen, S., Wang, H., McCarthy, A. D., Yan, Z., Kim, H. J., Carlson, M. A., Younan Xia, A., & Xie, J. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b00217 · Cited by 85 · see citing works
Bioengineering approaches to treat the failing heart: from cell biology to 3D printing
Yadid, M., Oved, H., Silberman, E., & Dvir, T. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00603-7 · Cited by 83 · see citing works
Engineering a living cardiac pump on a chip using high-precision fabrication
Michas, C., Karakan, M. Ç., Nautiyal, P., Seidman, J. G., Seidman, C. E., Agarwal, A., Ekinci, K., Eyckmans, J., White, A. E., & Chen, C. S. (2022) · Science Advances · doi:10.1126/sciadv.abm3791 · Cited by 82 · see citing works
Criscione, J. D., Rezaei, Z., Cantu, C. M. H., Murphy, S. A., Shin, S. R., & Kim, D. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114840 · Cited by 78 · see citing works
Microengineered platforms for characterizing the contractile function of in vitro cardiac models
Dou, W., Malhi, M., Zhao, Q., Wang, L., Huang, Z., Law, J., Liu, N., Simmons, C. A., Maynes, J. T., & Sun, Y. (2022) · Microsystems & Nanoengineering · doi:10.1038/s41378-021-00344-0 · Cited by 80 · see citing works
Chantre, C. O., Gonzalez, G. M., Ahn, S., Cera, L., Campbell, P. H., Hoerstrup, S. P., & Parker, K. K. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b17322 · Cited by 76 · see citing works
Self-citationReconstructing the heart using iPSCs: Engineering strategies and applications
Cho, S., Lee, C., Skylar‐Scott, M. A., Heilshorn, S. C., & Wu, J. C. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.04.006 · Cited by 71 · see citing works
“ring-shaped EHTs [117,118], and chamber-forming ventricle models [119].”
BackgroundDirect 3D‐Bioprinting of hiPSC‐Derived Cardiomyocytes to Generate Functional Cardiac Tissues
Esser, T. U., Anspach, A., Muenzebrock, K. A., Kah, D., Schrüfer, S., Schenk, J., Heinze, K. G., Schubert, D. W., Fabry, B., & Engel, F. B. (2023) · Advanced Materials · doi:10.1002/adma.202305911 · Cited by 75 · see citing works
Hwang, D. G., Choi, Y., & Jang, J. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.685507 · Cited by 74 · see citing works
Cells, Materials, and Fabrication Processes for Cardiac Tissue Engineering
Montero, P., Flandes‐Iparraguirre, M., Musquiz, S., Pérez-Araluce, M., Plano, D., Sanmartín, C., Orive, G., Gavira, J. J., Prósper, F., & Mazo, M. M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00955 · Cited by 69 · see citing works
From engineered heart tissue to cardiac organoid
Cho, J., Lee, H., Rah, W., Chang, H., & Yoon, Y. (2022) · Theranostics · doi:10.7150/thno.67661 · Cited by 66 · see citing works
“[66] hiPSC-CMs (1 x 106) M199 plus vitamin B12”
BackgroundMethodInfluentialAlfalfa Nanofibers for Dermal Wound Healing
Ahn, S., Ardoña, H. A. M., Campbell, P. H., Gonzalez, G. M., & Parker, K. K. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b07626 · Cited by 64 · see citing works
Self-citationCurrent challenges in three-dimensional bioprinting heart tissues for cardiac surgery
Roche, C. D., Brereton, R. J. L., Ashton, A. W., Jackson, C., & Gentile, C. (2020) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezaa093 · Cited by 59 · see citing works
Engineering aligned human cardiac muscle using developmentally inspired fibronectin micropatterns
Batalov, I., Jallerat, Q., Kim, S., Bliley, J. M., & Feinberg, A. W. (2021) · Scientific Reports · doi:10.1038/s41598-021-87550-y · Cited by 63 · see citing works
Harnessing organs-on-a-chip to model tissue regeneration
Tavakol, D. N., Fleischer, S., & Vunjak‐Novakovic, G. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.05.008 · Cited by 66 · see citing works
Dwyer, K. D., & Coulombe, K. L. K. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.12.015 · Cited by 61 · see citing works
Dudek, K. K., Kadic, M., Coulais, C., & Bertoldi, K. (2025) · Nature Reviews Materials · doi:10.1038/s41578-025-00828-9 · Cited by 74 · see citing works
“The ability to program specific shape changes into structures opens up numerous compelling applications in deployable and reconfigurable materials and structures [1, 2, 3, 4], robotics [5, 6, 7], and biomedical devices [8, 9].”
Current Applications of Polycaprolactone as a Scaffold Material for Heart Regeneration
Schmitt, P. R., Dwyer, K. D., & Coulombe, K. L. K. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00174 · Cited by 60 · see citing works
Extracellular Vesicles in Cardiac Regeneration: Potential Applications for Tissues-on-a-Chip
Wagner, K. T., Nash, T. R., Liu, B., Vunjak‐Novakovic, G., & Radisic, M. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.08.005 · Cited by 49 · see citing works
“Common models include elongated or planar tissues suspended between pillars [41–43], planar tissues attached to flexible substrates [44,45], spheroids [46–48] or tubular tissues [49] in microwells, ring-shaped tissues looped around support posts [50–52], elongated tissues suspended along wire filaments [53], web-like…”
BackgroundA combined human gastruloid model of cardiogenesis and neurogenesis
Olmsted, Z. T., & Paluh, J. L. (2022) · iScience · doi:10.1016/j.isci.2022.104486 · Cited by 55 · see citing works
Park, C., Fan, Y., Hager, G., et al. (2020) · Science Robotics · doi:10.1126/scirobotics.aay9106 · Cited by 53 · see citing works
Standardizing designed and emergent quantitative features in microphysiological systems
Nahon, D. M., Moerkens, R., Aydoğmuş, H., Lendemeijer, B., Martínez-Silgado, A., Stein, J. M., Dostanić, M., Frimat, J., Gontan, C., de Graaf, M. N. S., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01236-0 · Cited by 62 · see citing works
“Steps towards macroscale heart chamber geometries have been made by creating ellipsoidal nanofibrous scaffolds, compatible with microfluidic systems and the application of exogenous pressure, seeded with ventricular cardiomyocytes derived from human induced pluripotent stem cells 15 (hiPSCs).”
Ho, B. X., Pang, J. K. S., Phua, Q. H., Liew, L. C., Poh, B. M., Chen, Y., Loh, Y.-H., An, Ö., Yang, H. H., Seshachalam, V. P., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03215-1 · Cited by 58 · see citing works
Progress in Organ Bioprinting for Regenerative Medicine
Wang, X. S., Zhang, D., Singh, Y. P., Yeo, M., Deng, G., Lai, J., Chen, F., Ozbolat, I. T., & Yu, Y. (2024) · Engineering · doi:10.1016/j.eng.2024.04.023 · Cited by 59 · see citing works
“External interventions such as cellular or extracellular stimuli (e.g., electrical field stimulation and 3D contractile chambers) have also been applied to bioprinted heart models to mimic physiological conditions and accelerate tissue maturation [276–278].”
A framework for developing sex-specific engineered heart models
Lock, R., Al Asafen, H., Fleischer, S., Tamargo, M., Zhao, Y., Radisic, M., & Vunjak-Novakovic, G. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00381-1 · Cited by 50 · see citing works
Emerging Bioelectronic Strategies for Cardiovascular Tissue Engineering and Implantation
Cox‐Pridmore, D. M., de Castro, F. A., Silva, S. R. P., Camelliti, P., & Zhao, Y. (2022) · Small · doi:10.1002/smll.202105281 · Cited by 47 · see citing works
Macrophages enhance contractile force in iPSC-derived human engineered cardiac tissue
Lock, R. I., Graney, P. L., Tavakol, D. N., Nash, T. R., Kim, Y., Sanchez, E., Morsink, M. A. J., Ning, D., Chen, C., Fleischer, S., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114302 · Cited by 48 · see citing works
In Vitro Methods to Model Cardiac Mechanobiology in Health and Disease
Jorba, I., Mostert, D., Hermans, L. H. L., van der Pol, A., Kurniawan, N. A., & Bouten, C. V. C. (2021) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2020.0342 · Cited by 48 · see citing works
“By means of advanced 3D bioprinting and electrospinning techniques the characteristic ECM fiber anisotropy has been mimicked while building a left ventricle chamber of few millimeters.(95,96) The scaffolds were seeded with iPSC derived cardiomyocytes and showed functional electrophysiological activity leading to contr…”
MethodMulti-directional cellular alignment in 3D guided by electrohydrodynamically-printed microlattices
Mao, M., He, J., Li, Z., Han, K., & Li, D. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.10.028 · Cited by 48 · see citing works
Recent Advances in Generation of In Vitro Cardiac Organoids
Sahara, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076244 · Cited by 47 · see citing works
“In regards to topics of other in vitro 3D culture models, including various EHT models [16,26], a microfluidics/heart-on-a-chip [27,28], bioprinting [29,30], and electrospinning [31,32], the author asks readers to refer to the suggested reviews, respectively.”
BackgroundSchwach, V., Slaats, R. H., & Passier, R. C. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00050 · Cited by 45 · see citing works
“Similarly, Macqueen and colleagues generated a one cell layer thick ventricular-like tube from hPSCcardiomyocytes (131).”
Methodde Korte, T., Katili, P. A., Yusof, N. A. N. M., van Meer, B. J., Saleem, U., Burton, F. L., Smith, G. L., Clements, P., Mummery, C. L., Thomas Eschenhagen, A., et al. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023309 · Cited by 41 · see citing works
Mao, M., Qu, X., Zhang, Y., Gu, B., Li, C., Liu, R., Li, X., Zhu, H., He, J., & Li, D. (2023) · Nature Communications · doi:10.1038/s41467-023-37716-1 · Cited by 42 · see citing works
“Previously, numerous synthetic scaffolds consisting of highly aligned microfabricated grooves or electrospun micro/nano-fi bers have been developed to mimic the anisotropic myocardial architecture, providing the topographical cues to direct cell orientation 15 – 18 .”
Fang, Y., Sun, W., Zhang, T., & Xiong, Z. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2021.121298 · Cited by 40 · see citing works
Engineering anisotropic 3D tubular tissues with flexible thermoresponsive nanofabricated substrates
Williams, N. P., Rhodehamel, M., Yan, C., Smith, A. S. T., Jiao, A., Murry, C. E., Scatena, M., & Kim, D. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119856 · Cited by 41 · see citing works
Fiber Scaffold Patterning for Mending Hearts: 3D Organization Bringing the Next Step
Kristen, M., Ainsworth, M. J., Chirico, N., van der Ven, C. F. T., Doevendans, P. A., Sluijter, J. P. G., Malda, J., van Mil, A., & Castilho, M. D. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900775 · Cited by 40 · see citing works
Sewanan, L. R., & Campbell, S. G. (2019) · The Journal of Physiology · doi:10.1113/jp276753 · Cited by 36 · see citing works
“2016) and even cardiac mini-chamber organoids (MacQueen et al. 2018; Li et al. 2018a) (Fig.”
BackgroundCardiac Organoids: A 3D Technology for Modeling Heart Development and Disease
Zhu, L., Liu, K. Y., Feng, Q., & Liao, Y. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10385-1 · Cited by 41 · see citing works
From tissue engineering to engineering tissues: the role and application of in vitro models.
Pacheco, D. P., Vargas, N. S., Visentin, S., & Petrini, P. (2020) · Biomaterials Science · doi:10.1039/d0bm01097a · Cited by 23 · see citing works
Homma, J., Shimizu, S., Sekine, H., Matsuura, K., & Shimizu, T. (2020) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3074 · Cited by 33 · see citing works
“…the seeding of cells on aligned nanofibers and culture for several days (Han, Wu, Xia, Wagner, & Xu, 2016; Li et al., 2017; Lin et al., 2014; MacQueen et al., 2018), the seeding of cells on a matrix in a patterned mold (Nakane et al., 2017), and the seeding of cells into a collagen gel…”
BackgroundMethodEngineering and Assessing Cardiac Tissue Complexity
Tadevosyan, K., Iglesias‐García, O., Mazo, M. M., Prósper, F., & Raya, Á. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031479 · Cited by 34 · see citing works
“The authors showed that cells aligned following the fiber orientation, thus recapitulating the orientation of the native myocardium, although the contractile function was much smaller than those of the native rat/human ventricles most likely owing to the small thickness of the chamber [203].”
BackgroundProgress in Bioengineering Strategies for Heart Regenerative Medicine
Häneke, T., & Sahara, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073482 · Cited by 32 · see citing works
“ning [145,146], Microfluidic chip [151], Muscle strip (ring shaped EHT) [40], Dynamic culture (cardiobundles) [137], Micro heart muscle arrays [76], BiowireTM [45,152]; 4.”
BackgroundBuilding an Artificial Cardiac Microenvironment: A Focus on the Extracellular Matrix
Pagliarosi, O., Picchio, V., Chimenti, I., Messina, E., & Gaetani, R. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.559032 · Cited by 34 · see citing works
Melle, G., Bruno, G., Maccaferri, N., Iachetta, G., Colistra, N., Barbaglia, A., Dipalo, M., & Angelis, F. D. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00066 · Cited by 34 · see citing works
“058 m·s−1, which is comparable to values measured for the same cells in other works (Macqueen et al., 2018).”
ResultInfluentialWhole-Heart Tissue Engineering and Cardiac Patches: Challenges and Promises
Akbarzadeh, A., Sobhani, S., Khaboushan, A. S., & Kajbafzadeh, A. M. (2023) · Bioengineering · doi:10.3390/bioengineering10010106 · Cited by 32 · see citing works
“The ejection fractions and contractile work were ~50–250 and ~104–108 smaller than the physiologic values rodent and human ventricles, respectively [50].”
BackgroundA Change of Heart: Human Cardiac Tissue Engineering as a Platform for Drug Development
Bremner, S. B., Gaffney, K. S., Sniadecki, N. J., & Mack, D. L. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01668-7 · Cited by 29 · see citing works
de Almeida, H. V., Tenreiro, M. F., Louro, A. F., Abecasis, B., Santinha, D. R., Calmeiro, T., Fortunato, E. M. C., Ferreira, L., Alves, P. M., & Serra, M. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01490 · Cited by 30 · see citing works
The harder the climb the better the view: The impact of substrate stiffness on cardiomyocyte fate
Querceto, S., Santoro, R., Gowran, A., Grandinetti, B., Pompilio, G., Regnier, M., Tesi, C., Poggesi, C., Ferrantini, C., & Pioner, J. M. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.02.001 · Cited by 34 · see citing works
Wu, Q., Xue, R., Zhao, Y., Ramsay, K., Wang, E. Y., Savoji, H., Veres, T., Cartmell, S. H., & Radisic, M. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.10.019 · Cited by 26 · see citing works
“Ultimately, the engineered human left ventricle [73,74], and a 3D bioprinted ventricle model [75] may replace trabeculae-like structures in drug development and disease modelling, due to their conceptual ability to predict ventricle dilatation and remodeling, as well as the ability to capture…”
BackgroundTissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing
Donoghue, L., Nguyen, K. T. V., Graham, C., & Sethu, P. (2021) · Micromachines · doi:10.3390/mi12020139 · Cited by 31 · see citing works
“fabricated models of the left ventricle that more accurately mimicked ellipsoidal ventricular geometry via the pull-spinning of biocompatible, biodegradable polycaprolactone/gelatin nanofibers [61].”
MethodCardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies
Seguret, M., Vermersch, E., Jouve, C., & Hulot, J. (2021) · Biomedicines · doi:10.3390/biomedicines9050563 · Cited by 27 · see citing works
Mohammadi, M. H., Okhovatian, S., Savoji, H., Campbell, S. B., Lai, B. F. L., Wu, J., Pascual‐Gil, S., Bannerman, D., Rafatian, N., Li, R., et al. (2022) · Advanced Biology · doi:10.1002/adbi.202101165 · Cited by 28 · see citing works
Tissue-engineered heart chambers as a platform technology for drug discovery and disease modeling
Mousavi, A., Stefanek, E., Jafari, A., Ajji, Z., Naghieh, S., Akbari, M., & Savoji, H. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212916 · Cited by 27 · see citing works
Soft bioelectronics for cardiac interfaces
Tang, X., He, Y., & Jia Liu, B. (2022) · Biophysics Reviews · doi:10.1063/5.0069516 · Cited by 23 · see citing works
Wu, H., Shi, S., Liu, Y., Zhang, Q., Lam, R. H. W., Lim, C. T., & Hu, J. (2023) · Biofabrication · doi:10.1088/1758-5090/acdaf9 · Cited by 23 · see citing works
“Isoproterenol, a synthetic catecholamine, restores cardiomyocyte beating by inducing positive inotropic and chronotropic responses [147, 148].”
Bioengineering Clinically Relevant Cardiomyocytes and Cardiac Tissues from Pluripotent Stem Cells
James, E. C., Tomaskovic‐Crook, E., & Crook, J. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063005 · Cited by 23 · see citing works
Lee, J., Park, D., Seo, Y., Chung, J. J., Jung, Y., & Kim, S. H. (2020) · Advanced Materials · doi:10.1002/adma.202002096 · Cited by 24 · see citing works
Stem Cells and Their Cardiac Derivatives for Cardiac Tissue Engineering and Regenerative Medicine
Roshanbinfar, K., Esser, T. U., & Engel, F. B. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8193 · Cited by 24 · see citing works
“Inpreclinicaltrials,sixadult Yucata´npigsandfouradultmongreldogswere subjectedto‘‘fullthicknesscirculardefects’’and treatedwithsmallintestinalsubmucosa-ECM.”
InfluentialModelling genetic diseases for drug development: Hypertrophic cardiomyopathy
Santini, L., Palandri, C., Nediani, C., Cerbai, E., & Coppini, R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105176 · Cited by 24 · see citing works
“Among the different tools used to study the heart in depth [200], cell culture is fundamental to understand multiple mechanisms responsible for cell behavior in vivo, uncovering different”
MethodDaly, A. C., Davidson, M. D., & Burdick, J. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.21.103127 · Cited by 24 · see citing works
Engineering biomimetic and instructive materials for wound healing and regeneration
Chantre, C. O., Hoerstrup, S. P., & Parker, K. K. (2019) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2019.04.004 · Cited by 32 · see citing works
Self-citationMao, M., Han, K., Gao, J., Ren, Z., Zhang, Y., He, J., & Li, D. (2025) · Advanced Materials · doi:10.1002/adma.202419380 · Cited by 23 · see citing works
Lou, L., Rubfiaro, A. S., Deng, V., He, J. M., Thomas, T., Roy, M., Dickerson, D. A., & Agarwal, A. K. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c06505 · Cited by 23 · see citing works
Cardiac fibroblast BAG3 regulates TGFBR2 signaling and fibrosis in dilated cardiomyopathy
Wang, B. Z., Morsink, M. A. J., Kim, S. W., Luo, L. J., Zhang, X., Soni, R. K., Lock, R. I., Rao, J., Kim, Y., Zhang, A., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci181630 · Cited by 22 · see citing works
“Our laboratory and others have demonstrated the ability of hiPSC-based engineered tissues to model cardiac development, elucidate normal and pathological function, and parse out the respective contributions of CMs and supporting cells (21–25).”
Reactive Cell Electrospinning of Anisotropically Aligned and Bilayer Hydrogel Nanofiber Networks
Dawson, C. J., Xu, F., & Hoare, T. R. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01013 · Cited by 24 · see citing works
Developmental co-emergence of cardiac and gut tissues modeled by human iPSC-derived organoidsPreprint
Silva, A. C., Rubio, O., Joy, D. A., Kauss, M. A., Natarajan, V., Lai, M. H., Turaga, D., Blair, A. P., Alexanian, M., Bruneau, B. G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.30.071472 · Cited by 21 · see citing works
Gu, B., Han, K., Cao, H., Huang, X., Li, X., Mao, M., Zhu, H., Cai, H., Li, D., & He, J. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100914 · Cited by 23 · see citing works
“9D) [112].”
Engineering Heart Morphogenesis
Mandrycky, C., Williams, N. P., Batalov, I., El‐Nachef, D., de Bakker, B. S., Davis, J., Kim, D., DeForest, C. A., Zheng, Y. Y., Stevens, K. R., et al. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.01.006 · Cited by 19 · see citing works
Fabrication of human myocardium using multidimensional modelling of engineered tissues
Montero‐Calle, P., Flandes‐Iparraguirre, M., Mountris, K. A., Nava, A., Laita, N., Rosales, R. M., Iglesias‐García, O., De‐Juan‐Pardo, E. M., Atienza, F., Fernández‐Santos, M. E., et al. (2022) · Biofabrication · doi:10.1088/1758-5090/ac8cb3 · Cited by 20 · see citing works
Modeling Cardiac Arrhythmias With Organoids
Hulot, J. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.076 · Cited by 18 · see citing works
A perspective on the use of light as a driving element for bio-hybrid actuation
Vurro, V., Venturino, I., & Lanzani, G. (2022) · Applied Physics Letters · doi:10.1063/5.0078411 · Cited by 15 · see citing works
Colzani, M., Malcor, J.-D. M., Hunter, E. J., Bayraktar, S., Polkinghorne, M., Krieg, T., Cameron, R. E., Best, S. M., Farndale, R. W., & Sinha, S. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120612 · Cited by 17 · see citing works
Dwyer, K. D., Kant, R. J., Soepriatna, A. H., Roser, S. M., Daley, M. C., Sabe, S. A., Xu, C., Choi, B., Sellke, F. W., & Coulombe, K. L. K. (2023) · Bioengineering · doi:10.3390/bioengineering10050587 · Cited by 17 · see citing works
Deidda, V., Ventisette, I., Langione, M., Giammarino, L., Pioner, J. M., Credi, C., & Carpi, F. (2024) · Journal of Functional Biomaterials · doi:10.3390/jfb15100297 · Cited by 15 · see citing works
“…the ability of pluripotent stem cells (PSCs) to differentiate into all tissue types, including cardiac cells; indeed, their use in combination with new biomaterials, capable of emulating the behaviour of the extracellular matrix, represents a new frontier in the realm of cardiac regeneration [2,3].”
BackgroundCyr, J. A., Colzani, M., Bayraktar, S., Köhne, M., Bax, D. V., Graup, V., Farndale, R. W., Sinha, S., Best, S. M., & Cameron, R. E. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213680 · Cited by 17 · see citing works
“Calcium fluorescence patterns serve as a surrogate for action potential propagation and describe excitation-contraction coupling kinetics [20,27].”
BackgroundWhole Heart Engineering: Advances and Challenges
Morrissey, J., Mesquita, F., Hochman‐Mendez, C., & Taylor, D. A. (2021) · Cells Tissues Organs · doi:10.1159/000511382 · Cited by 15 · see citing works
“tion) in the produced constructs remains crude [MacQueen et al., 2018].”
BackgroundConstantinou, C., Miranda, A. M. A., Cháves, P., Bellahcene, M., Massaia, A., Cheng, K., Samari, S., ROTHERY, S. M., Chandler, A. M., Schwarz, R. P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-69495-w · Cited by 14 · see citing works
Multi-cellularity in cardiac tissue engineering, how close are we to native heart tissue?
Owen, T. J., & Harding, S. E. (2019) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-019-09528-8 · Cited by 14 · see citing works
Parvatam, S., Pamies, D., Pistollato, F., Beken, S., Mariappan, I., Roth, A. B., Piergiovanni, M., Maisonneuve, B. G. C., Ewart, L. C., Majumder, A., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.11.008 · Cited by 17 · see citing works
- Authors
- MacQueen, L. A., Sheehy, S. P., Chantre, C. O., Zimmerman, J. F., Pasqualini, F. S., Liu, X., Goss, J. A., Campbell, P. H., Gonzalez, G. M., Park, S.-J., Capulli, A. K., Ferrier, J. P., Kosar, T. F., Mahadevan, L., Pu, W. T., & Parker, K. K.
- Affiliations
- Harvard University (US)
- Boston Children's Hospital (US)
- Corresponding author
- Parker, Kevin Kit
- ORCID
- Venue
- Nature Biomedical Engineering
- Published
- 2018-07-23
- Volume
- 2
- Issue
- 12
- Pages
- 930-941
- ISSN
- 2157-846X (ISSN-L)
- PMC
- PMC6774355
- OpenAlex
- W2884444313
- Semantic Scholar
- fe2a5e78ca3d5d351aa428f530fae947c66402fc
- Cited by
- 227
- References
- 84
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 27 · 2023: 30 · 2022: 41 · 2021: 34 · 2020: 35 · 2019: 21 · 2018: 2
- FWCI
- 23.91
- Type
- journal article
- Language
- en
- Update notices
- addendum (2022-03-08)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UH3TR000522)
- National Heart, Lung, and Blood Institute (UH3HL141798, UG3HL141798)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Materials Science › Biomaterials › Electrospun Nanofibers in Biomedical Applications
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- left ventricle, nanofibrous scaffolds, cardiomyocytes, iPSC-derived cardiomyocytes, ejection fraction, pressure-volume loops, ventricular assist, bioreactors
- MeSH terms
- Animals, Arrhythmias, Cardiac, Extracellular Matrix, Heart Ventricles, Humans, Models, Biological, Myocardial Contraction, Polymers, Ventricular Function, Computer-Aided Design, Rats, Sprague-Dawley, Tissue Engineering, Myocytes, Cardiac, Rats, Tissue Scaffolds, Induced Pluripotent Stem Cells, Nanofibers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review